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RESUME 
Vers l'objectif de crger ou remplacer des tissus endommag€s, il est essentiel d'6tablir un 
proc£d6 pouvant r6pondre aux multiples demandes biologiques. La culture sur p£tri ou en 
deux dimensions n'a qu'un potentiel tr£s limits dfi aux limitations, en autres, de 
1'approvisionnement en oxygfcne. 
Dans ce projet, un bioproc6d£ autonome et complet a 6t6 mis en place afin de r£pondre & ces 
besoins cellulaires. Le rgacteur est versatile puisque plusieurs designs de chambres de culture 
peuvent y etre connects. Le pH et la concentration en oxyg£ne y sont modules par deux 
contrdleurs PI. La pression, la temperature et le d£bit volum£trique sont constamment 
enregistrds. Un pulsateur permet de mimer la pulsation cr£ee par le cceur. 
Dans ce memoire, afin de caracteriser le r£acteur, les r£sultats d'une analyse RTD seront 
presents. Des mesures de perm6abilit£ si I'aide d'une sonde fluorescente et de diffusion par 
imagerie par resonance magn&ique (IRM) permettront de caracteriser plus sp£cifiquement la 
chambre de culture cellulaire. II sera brifcvement d£montr£ comment le r£acteur a 6x6 optimist 
afin de rdduire les risques de contaminations, ligalement, la procedure pour d6velopper les 
outils de controle PI sera d£taill£e. Finalement, deux designs de chambre de culture seront 
pr6sent£s afin de cr6cr des micro-vaisseaux sanguins. 
MOTS CLES : bior6acteur & perfusion, analyse RTD, permlabilitl, coefficient de diffusion 
apparent, controleur PI, chambre de culture cellulaire, orientation de micro-vaisseaux 
sanguins, cellules endothelials. 
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SUMMARY 
Toward the objective to create or to replace impaired tissues, it is essential to establish a 
culture process allowing tissue growth in vitro. The Petri dish culture or the traditional 2D 
culture has only a limited potential, mainly caused by a poor oxygen mass transfer to feed 
larger tissue constructs. 
In this project, an autonomous and complete bioprocess has been built to fullfill these needs. 
The developed reactor is versatile because many cell culture chamber designs can be 
connected to it. Two proportional-integral algorithms (PI) can control the dissolved oxygen 
concentration and the pH. The pressure, the temperature and mass flow rate are recorded in 
real time. An actuator allows mimicking the cardiac output flow. 
In this memoire, it will be demonstrated how the reactor has been optimized to reduce the risk 
of bioburden. Also, the procedures to develop the control tools of the PI algorithm will be 
detailed. To characterize the reactor, a RTD study will be presented. To characterize the cell 
culture chamber, a permeability analysis using fluorescent microscopy and magnetic 
resonance imaging (MRI) will be exposed. Finally, two cell culture chamber designs to orient 
microvessel formation have been tested and these results will be presented. 
KEYWORDS: RTD analysis, permeability, apparent diffusion coefficient, PI controller, cell 
culture chamber. 
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ACRONYMES 
2D/3D: two dimensions/three dimensions 
ADC: apparent diffusion coefficient 
ADH: antidiuretic hormone 
ANP: atrial natriuretic peptide 
BSA: bovine serum albumine 
CFD: computational fluid dynamics 
CFSE: carboxyfluorescein succinimidyl ester 
CSTR: continuous-stirred tank reactor 
CVD: cardiovascular disease(s) 
DMSO: dimethyl sulfoxide 
DNA: deoxyribonucleic acid 
DAPI: 4',6-diamidino-2-phenylindole 
DO: dissolved oxygen 
ECGS: endothelial cell growth supplement 
ECM: extracellular matrix 
eNOS: endothelial nitric oxide synthase 
FBS: fetal bovine serum 
FOPDT: first-order plus dead time 
HBSS: Hank's balanced salt solution 
HUVEC: human umbilical vein endothelial cell 
ID: internal diameter 
LSQ: least square fit 
PBS: phosphate buffer solution 
PDGF: platelet-derived growth factor 
PET: positron emission tomography 
P: proportional 
PD: proportional-derivative 
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PFA: paraformaldehyde 
PI: proportional-integral 
PID: proportional-integral-derivative 
MMP: matrix metalloproteinase 
MRI: magnetic resonance imaging 
mTG: m-transglutaminase 
NO: nitric oxide 
R&D: research and development 
ROI: region of interest 
RGD: Arginine-Glycine-Aspartic acid 
RTD: residence time distribution 
SISO: single input single output 
SOP: standardized operational procedures 
VEGF: vascular endothelial growth factor 
vWF: von Willebrand factor 
Introduction generate 
Section 1.1: Mise en contexte 
1.1.1 Les maladies cardiovasculaires et le genie tissulaire 
L'ing£nierie tissulaire ou la m&iecine r£g£n£ratrice est une science progressiste 
combinant la biologie fondamentale, la chimie (materiaux) et l'ingenierie. Le but de 
l'ingenierie tissulaire est d'ameiioier, de cr^er ou de Sparer des organes ou des tissus humains 
(ex.: os, tendon, valve cardiaque, etc.). 
Malgrd un d&lin pendant les 40 derni&res ann^es, les maladies cardiovasculaires 
(CVD) etaient toujours en 2006 la cause la plus importante de mortality (30% de tous les 
d6c£s) [Heart and stroke foundation (http://www.heartandstroke.com/site/c.iklOLcMWJtE/b-
.348399l/k.34A8/Statistics.htm#heartdisease)]. remplac^es depuis peu par le cancer de 2006 
k aujourd'hui [1]. Les coflts engendrgs par ces maladies au Canada sont lvalues k 22.2 
milliards de dollars par ann£e [2]. 
Les CVD mgritent amplement tout l'effort de recherche et d^veloppement (R&D) 
g6n£r6 dans le secteur du genie tissulaire. II existe une application indirecte tout aussi 
importante dans l'ingenierie vasculaire du systfcme circulatoire (artfcres, veines, capillaires). 
Puisque chaque cellule du corps humain doit 6tre & moins de 100pm d'une source sanguine, 
n'importe quel substitut de tissus humains devrait etre systematiquement accompagne d'un 
reseau vasculaire fonctionnel ou d'une alternative pour l'alimenter (bioprocedes). Les 
fonctions d'un reseau vasculaire sont [3]: 
• Alimenter les cellules (sucies, O2, vitamines, etc.) ; 
• Enlever les dechets (metaboliques); 
• Fournir une stimulation mecanique necessaire (contrainte de cisaillement, pulsation, 
etc.). 
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Dans les deux prochaines sections, l'ingenierie vasculaire du syst&me circulatoire et les 
biorgacteurs seront introduits comme les 2 voies essentielles pour cr6er des substituts de tissus 
in vitro. 
1.1.2 L'ingenierie vasculaire du syst&me circulatoire 
L'ingenierie vasculaire du systeme circulatoire est seulement une sous-section de 
ringenierie tissulaire qui se concentre sur les veines, les art&res et les capillaires. Cette sous-
section peut etre divisee comme suit: 
• angiogenic (formation de vaisseaux sanguins a partir de structures preexistantes); 
• vasculogen^se (formation de vaisseaux sanguins utilisant des cellules progenitrices ou 
cellules souches); 
• substituts synthetiques pour petits et larges vaisseaux sanguins. 
Depuis longtemps, la vasculogen£se in vivo etait un phenom^ne qu'on croyait arriver 
uniquement au stade embryonnaire. Cependant, des etudes ont demontre que la vasculogendse 
in vivo pouvait survenir au stade adulte durant les cycles menstruels [4] et dans le 
developpement de tumeurs [5]. La vasculogen&se in vitro, d'un autre c6te, est basee sur la 
capacite des cellules souches ou progenitrices k creer un equivalent de structure vasculaire en 
dehors du corps. 
Les capillaires ont un contact direct avec les tissus et fournissent la zone d'echanges 
essentielle pour la survie et la croissance des tissus. Les capillaires sont les types de vaisseaux 
sanguins les plus simples puisqu'une unique couche de cellules endotheliales avec un basal 
lamina forme sa structure. Quelquefois, une seule cellule peut couvrir enticement le diam&tre 
de la lumi£re [6]. Malheureusement, la culture de cellules endotheliales jusqu'i la confluence 
est encore bien loin d'un vaisseau sanguin fonctionnel. Les cellules endotheliales de vaisseaux 
sanguins sont liees ensemble par des jonctions serrees ou relachees et sont allongees dans le 
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sens de l'ecoulement comparativement k la culture en statique. Le diamdtre moyen de la 
lumiere d'un capillaire est de 8-9|im avec une epaisseur de parois de 0.5jun [6]. 
II existe trois types de capillaires : continus, fenetres et discontinus [7]. Chacun de ces 
types est base sur la taille des pores presentes et consgquemment, sur les molecules qui 
peuvent pgnetrer ou sortir. Les capillaires continus n'ont aucune taille sp^cifique et 
permettent seulement aux ions et k l'eau de diffuser. Les capillaires fenetres ont des pores de 
60-80 nm qui laissent passer les petites prolines par diffusion et finalement, les capillaires 
discontinus ont des pores de 30-40 tun qui, combines £ un manque de basal lamina et de 
fonctions gap entre les cellules, permettent k des globules rouges et des prolines du serum de 
penetrer [7]. L'endothelium peut aussi echanger des nutriments et des molecules par 
pinocytose et par les v6sicules de transport, comme transport actif. 
L'endothelium interagit aussi avec son environnement en s£crgtant ou en r^agissant & 
divers stimuli. Plusieurs de ces stimuli sont essentiels pour l'h£mostase (ex. : epinephrine, 
hormones antidiuretiques (ADH), ANP) et ne sont pas naturellement disponibles pour tester 
dans des conditions in vitro puisque ces derniers sont produits par d'autres organes pour varier 
la pression et le volume sanguins [6]. Cependant, il existe d'autres stimuli chimiques qui 
jouent un role direct sur la reponse de l'endothelium comme l'angiotensine II, l'endotheiine, le 
PDGF, l'oxyde nitrique (NO), l'histamine, la prostacycline et plusieurs autres. La production 
de ces molecules ou la reponse a ces molecules (vaso-activite) pourrait etre un bon indicateur 
de la creation d'un vaisseau sanguin fonctionnel [6]. 
Les caracteristiques d'un vaisseau sanguin fonctionnel ne sont toujours pas etablies 
dans la litterature. Logiquement, un substitut vasculaire devrait avoir les memes attributs que 
les vaisseaux natifs [8]. Puisque l'hemostase est aussi reguiee par son environnement 
immediate (ex. : diaped&se, tissus/organes, etc.), il est alors impossible de valider in vitro 
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toutes les fonctions d'un vaisseau sanguin natif. Ainsi, quelques tests ont ete proposes dans le 
but de valider les vaisseaux sanguins. 
• pression d'gclatement [9, 10]; 
• mesures de conformite [9,10]; 
resistance a la intention de suture [9]; 
fatigue dynamique [9]; 
Validation physique 
fatigue statique [9]; 
vessel ringlet pull tests [10]; 
indice de rigidity [10]; ^ 
module elastique maximal [10]; 
activation du factor XII [11]; 
temps d'activation partielle de la thromboplastine (aPPT) [11] 
• eNOS [12]; > 
Encore une fois, I'absence d'un consensus pour valider les fonctions et les proprietes d'un 
vaisseau sanguin est causee par les interactions tr&s complexes entre l'endothelium et les 
composantes sanguines. Par consequent, il existe aucune fa^on de valider parfaitement la 
fonctionnalite des vaisseaux sanguins in vitro. La meilleure fa9on de valider un substitut in 
vitro reste l'implantation in vivo. 
Section 1.2: Definition du projet de recherche et objectifs 
L'objectif de ce projet est de caracteriser, d'optimiser et de valider un bioreacteur pour 
la croissance de structures semblables aux capillaires sanguins. Cela consiste & ameiiorer le 
systeme decrit par Chouinard et al. [13] par le design d'operations unitaires rgpondant aux 
adhesion plaquettaire [11]; Validation biochimique 
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besoins cellulaires. La plupart des articles sur les biorgacteurs n'est pas toujours relig & 
l'ingenierie vasculaire, prgsente des syst£mes monovalents et montre uniquement des 
observations reliees & la culture cellulaire sans aucune autre information sur le controle, 
l'automatisation et l'ltude du proc£d£. Essentiellement, les biorgacteurs devraient etre : 
polyvalents, capables de maintenir une experience de longue durge sans contaminations ou du 
moins en minimiser les risques, confus pour optimiser l'efficacite des operations unitaires et 
construits pour permettre un veritable contrdle des conditions de culture. 
La caracterisation de la dynamique d'ecoulement k I'aide de nombres adimensionnels 
ciblera les comportements non ideaux du syst&me en plus d'identifier les parametres les plus 
influents incluant la chambre de culture cellulaire. L'optimisation du procede sera developpee 
par l'introduction d'un controleur et par un meilleur design des operations unitaires. Les 
donnees experimentales, tant dans la caracterisation que dans l'optimisation doivent corrgler 
avec un module theorique base sur certaines hypotheses. Finalement, le bioprocede avec la 
chambre de culture cellulaire seront valides en performant une culture de 24 heures. 
Section 1.3: Contributions originates 
Tel que mentionne ci-dessus, les bioreacteurs rapportes dans la litterature sont mal 
caractgrises. Souvent, la dynamique des fluides calculee (Computational Fluid dynamics, 
CFD) est utilisee pour modeiiser l'ecoulement, malgre que cette technique est basee 
uniquement sur la simulation et non sur les donnees experimentales d'operation de procedes 
qui sont quasi inexistantes dans le secteur du genie tissulaire. Ici, une analyse de la 
distribution des temps de residence (.Residence Time Distribution, RTD) est presentee avec la 
dispersion comme source du comportement non-ideal en un axe. Une nouvelle equation pour 
l'ajustement des minima de la fonction RTD est decrite. Malgre que l'analyse demontre que la 
technique ne permet de detecter la presence de cellules a une certaine densite k 1'interieur d'un 
hydrogel, l'imagerie par resonance magnetique (Magnetic Resonance Imaging, MRI) est 
utilisee in vitro, dormant ainsi un certain rep&re sur les limites de detection de l'appareil k 
partir du coefficient de diffusion apparent {Apparent Diffusion Coefficient, ADC). 
L'application de cette chambre de culture cellulaire represente une nouveaute dans la 
litterature. Meme si le design de la chambre de culture cellulaire est similaire, les cellules sont 
cultiv^es sur les parois des canaux, en peripheric de l'hydrogel comparativement a l'utilisation 
rapportee par Chouinard et al. [13] ou la culture des cellules se faisait k l'int^rieur de 
l'hydrogel. Egalement, l'utilisation d'un melange de gelatine produite avec de la 
transglutaminase comme agent d'enchevetrement en tant qu'echafaudage est nouvelle. 
L'interieur des canaux est recouvert d'une couche de fibronectine qui peut se lier k la gelatine. 
Ainsi, P6chafaudage mime en quelque sorte la presence de prolines de la matrice 
extracellulaire (ExtraCellular Matrix, ECM). Finalement, I'implantation d'un algorithme pour 
le contrdleur proportionnel-int^gral (PI) pour moduler le pH et la concentration d'oxygdne 
dissout {Dissolved Oxygen, DO) est presentee. Jusqu'ici, la litterature ne semble pas utiliser 
les controleurs pour les bioreacteurs relics au genie tissulaire. Ainsi, la demarche scientifique 
et le choix des valeurs de contrdle sont expliqu^s. 
Section 1.4: Division des chapitres 
Ce memoire est pi€sent£ sous forme d'articles scientifiques. 
Le premier chapitre prgsente une revue de la litterature existante sur les bioreacteurs 
en ingenierie tissulaire (coauteurs: Yves Martin, Julie Chouinard, Roger Lecomte et Patrick 
Vermette). 
Le second chapitre presente une analyse de la distribution des temps de residence 
(RTD) et la caracterisation de la dynamique d'ecoulement du procede et de la chambre de 
culture cellulaire. Dans cette partie se trouvera : les calculs des nombres de Per et Re, l'effet 
de l'agitation, du debit volumetrique et du volume de la chambre de compliance sur la 
fonction RTD, l'&juation pour pr&lire les minima de la fonction RTD, l'effet de la density 
cellulaire sur l'ADC de 1'eau mesur6 par MRI et sur la permSabilM Cette section correspond 
au premier article scientifique present^ dans ce memoire (coauteurs: Luc Tremblay, Martin 
Lepage et Patrick Vermette). 
Le troisieme chapitre presente I'implantation du controleur proportionnel integral pour 
moduler le pH et la concentration en oxyg&ne dissout. Ce chapitre, sous forme d'article, d6crit 
les Stapes pour obtenir les variables et les simuler avec une Equation de premier ordre avec 
d£lai (FOPDT) (coauteurs: Andriy Shkilnyy, Georges Sabra, Jamie Sharp, Serge Gagnon, 
Pierre Proulx et Patrick Vermette). Finalement, un appendice au troisi&me chapitre presente 
les etapes qui ont men6 au design fuial du proc&te et aux differents designs de chambres de 
culture cellulaire. Les resultats de cultures cellulaires avec ces designs de chambre et les 
moyens utilises pour minimiser les risques de contamination sont Egalement montres dans cet 
appendice. 
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CHAPTER 1: BIOREACTORS AND THEIR 
OPERATION IN TISSUE ENGINEERING** 
** Le Chapitre 1 est adapts de Bioreactors for Tissue Engineering: Design, Applications and 
Monitoring, £crit par Justin Dubois, Yves Martin, Julie A. Chouinard, Roger Lecomte et 
Patrick Vermette et public dans "Comprehensive Biotechnology, 2nd edition", 6dit£ par 
Murray Moo-Young, Michael butler, Colin Webb, Antonio Moreira, Bernard Grodzinski, Z F 
Cui, Spiros Agathos. 
Our understanding of the engineering of tissue substitutes has been evolving since the 
last decade, but still a lot remains to be done. It is evident that the growth of tissue substitutes 
must rely on combined physical and (bio)chemical stimuli rather than solely on (bio)chemical 
ones. As addressed in this section, bioreactors can provide the required physical stimuli and 
also, a better nutrient distribution within cell aggregates. The use of well-designed bioreactors 
allows to apply engineering concepts in some "tissue engineering" applications, opening the 
possibility of dynamic cultures of larger 3D structures, as opposed to 2D cultures. The use of 
bioreactors introduces new pieces to an already complex puzzle. 
Bioreactors are often used to mimic in vitro the in vivo environment of the targeted 
tissue or organ. Given the embryonic status of bioreactor designs and their use in tissue 
engineering, each research team has its own vision of what parameters should be studied and 
what scale to select. This aspect added to the fact that a limited number of bioreactors are 
commercially available for tissue engineering results in a situation where researchers often 
build their own bioreactor based on their needs and specifications. One of the problems 
arising from the development and use of such custom-built bioreactors is the difficulty to 
transpose results or observations from one system to another, due to a lack of standardization. 
One way to avoid such a problem is to use dimensionless numbers in bioreactor design [1]. 
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As reviewed by Martin and Vermette [1], many reactors used in mammalian tissue 
engineering are designed to produce 2D constructs such as skin substitutes. These reactors, 
however, are of less interest to us because of the small thickness of the tissues produced, 
modifying the needs for mass transport in these reactor systems. The resulting 2D oriented 
reactor designs are therefore very different from the expected design of reactors built to grow 
larger tissue mass. Examples of reactors studied and/or used in tissue engineering are Petri 
dishes, continuous stirred tank reactors (CSTR), hollow fiber reactors, and rotating-wall 
perfused / Couette-Taylor reactors, only to name a few. The reader is referred to the previous 
review article [1] for more details on these particular bioreactors. 
The goal of this section is to review new development in the design and/or use of 
bioreactors in the tissue-engineering field since 2005. When possible, the rationale behind 
each reactor design is discussed. Also, the highlighted advantages and drawbacks related to 
the different reactor systems are presented. The reader is also invited to consult these reviews 
[2,3] and the following books [4-6] for supplement information on that subject. 
1.1 Bag bioreactors / wave and undertow bioreactors 
Possibly the simplest bioreactor to expose cells to dynamic and cyclic mechanical 
stimuli, bag bioreactors require minimum manipulations and adjustments. The principle 
behind simply consists in producing wave and undertow in a semi-closed vessel. Terrier and 
colleagues introduced such bioreactors for plant cell cultures, but the technology may also be 
transferred to anchorage-dependent cells with the introduction of a scaffold to support cells 
[7]. The intermittent rising and descending movement of the bag induces the formation of a 
wave and an undertow. Some parameters can be tuned to control the mixing, such as the time 
for the platform to raise and/or to descend as well as the time to remain in the upper or lower 
positions, the culture volume, the raising angle and the air inlet flow rate. A sterilizable 
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oxygen probe can be used to monitor the dissolved oxygen (DO) concentration. Bag 
bioreactors are disposable and can be autoclaved to achieve sterility. 
This technique has some advantages including facility to be sterilized, good heat 
transfer, aeration and oxygen monitoring. Moreover, wave-mixed bag bioreactors can be 
adapted in batch, fed-batch, continuous or continuous perfusion mode [7]. Some companies 
such as GE Healthcare and Sartorius Stedim Biotech sell pre-filled bag bioreactors already 
sterilized with the desired medium. 
Cell proliferation rates achieved in bag bioreactors can be equal and in some cases 
even better than other culture techniques such as the spinner flask and other rigid-wall 
reactors [18]. Also, Kilani and colleagues have shown higher oxygen transfer rate coefficient 
(faa) (up to 80h"') in vibrated pouch versus wave-induced bag bioreactor in yeast cultures [8]. 
To characterize the flow inside bag bioreactors, a new Reynold number has been introduced 
[7]: 
Re kVC (I) 
v(2h + B) 
where V represents the culture volume, C is a correction factor dependent on the bag type, 
the rocking rate, the rocking angle and the culture volume, k is the rocking rate, v is the 
kinematic viscosity, h is the liquid level and B the width of the culture bag. Other parameters 
such as the mixing time t„ (tm = time to reach 95% homogeneity) and the residence time 
distribution (RTD) could also be used to characterize such bioreactors. Bag bioreactors are 
often disposable and their working volume can range from 2L to 500L. 
However, the author believes that their applications are limited to thin tissue constructs or 
even just cells in suspension on microcarriers, as it is a challenge to perfuse culture medium 
within cell-seeded scaffolds using this reactor setup. 
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1.2 Perfusion bioreactors 
Perfusion bioreactors allow the convective flow of a culture medium through a bed of 
cells [5]. The bioreactor can either consist of scaffolds (seeded with cells) enclosed in a cell 
culture chamber with hollow fibers or with packed bed, fluidized bed and membranes to 
attach the cells. 
Our group has developed a perfusion bioreactor system [9]. This system has been used 
to culture endothelial cells seeded in fibrin which was perfused by hollow fibers inside the 
cell culture chamber [9]. Cell proliferation was very high using this perfusion system [9]. 
Also, perfusion of culture medium was necessary to keep cells alive, since cell death was 
mostly observed when cells were cultured in static inside a fibrin gel of similar dimensions 
incubated in a traditional CO2 incubator [9]. The system is made of many unit operations 
including a peristaltic pump, mass flow meters, gas and heat exchangers, a bubble trap, a 
pressure probe, O2 and pH probes and pulsation system. The process is able to control 
temperature, pH and DO concentration. These parameters are monitored by a computer 
program and recorded. The pulsation system can mimic physiological pulsative flow 
conditions to stimulate cells. Perfusion was characterized by injecting a food dye into the 
circulation and was found to be efficient [9]. 
The major advantages of this type of bioreactor are their versatility allowing the 
control over many process parameters. It also offers the possibility to carry out many cultures 
in parallel, as many cell culture chambers can be connected to the system at the same time. 
Drawbacks of such systems include the use of a larger volume of culture medium than that 
needed to fill the cell culture chamber, this extra volume is required to allow positioning the 
different probes and instruments for their use. Also, the sterilization procedure requires many 
steps and different methods. Furthermore, wash out in perfusion reactors has been reported 
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[10], although the system described by us [9] eliminates such problems, as the cells cannot 
exit the cell culture chamber given the small pore size of the hollow fibers. 
Bjork and colleagues [11], in a similar way than us [9], investigated the effect of flow 
pattern (axial flow, translumenal flow and combination of both) on cell growth inside a fibrin 
gel. The use of both axial and translumenal flows improved O2 distribution. However, 
detrimental effects related to burst pressure observed with axial flow and shear stress with 
translumenal flow, respectively, may occur in these systems. In perfusion bioreactors, as in 
other reactor systems, computational fluid dynamic (CFD) can be used to predict and 
optimize fluid flow distribution [10,12]. 
Jaasma et al. [13] used a simple form of perfusion bioreactor to evaluate the effects of 
different flow types over osteoblast proliferation and prostaglandin production. A decrease in 
cell proliferation rate and a significant boost of prostaglandin production was observed 
compared to static cultures. However, no significant differences were observed between the 
samples exposed to different types of flow (steady, pulsative, or oscillatory). A decrease in 
cell proliferation caused by dynamic flow has also been reported elsewhere [14]. Apart from 
cell proliferation, dynamic flow conditions has numerous other impacts on endothelial cells 
and these include elongation and orientation of cells in the direction of flow, alteration in F-
actin localization, disturbance in endocytosis, increase of LDL receptor expression and 
prostacyclin production and inhibition of cyclin-dependent kinase [14,15]. Mechanical stimuli 
have the potential to slow down DNA synthesis by inducing new shifts in the cell metabolism. 
However, it is not well understood how mechanical stimuli induce all these important changes 
in cells. Davies and colleagues [16] showed that for the same shear stress value, only 
turbulent flow resulted in an increase in cell proliferation suggesting that the flow type has 
considerable impact over the cell behavior for this cell type. The impact of turbulent flow has 
also been confirmed later [17]. 
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1.3 Biaxial bioreactors 
The principle behind biaxial bioreactors involves the rotation of an entire spherical 
reactor in two axes. Essentially, biaxial bioreactors are similar to the Slow Turning Lateral 
Vessel, as previously reviewed [1]. A scaffold is anchored inside the spherical vessel by pins. 
The reactor is connected with tubing to a reservoir that replenishes the medium by perfusion. 
Because the reservoir is placed in a CO2 incubator, pH, DO concentration and the temperature 
remain constant. However, the fact this system relies on an incubator limits its range of 
operating conditions and its control. 
Zhang et al. [18] used a biaxial bioreactor for the making of bone tissues from human 
fetal mesenchymal stem cells. Increase in cell proliferation, calcium deposition, alkaline 
phosphatase production and bony nodule formation were observed, when compared to static 
cultures. Also, in a biaxial bioreactor culture, cells remained alive up to a distance of 2000pm 
away from the oxygen source, while systems relying only on diffusion reduced that distance 
by 10 folds [ref. 14 in 1]. 
Biaxial reactors offer the advantage to enhance cell viability and to work with 3D 
constructs. It also induces low shear stress due to the rotating wall. 
1.4 Strain bioreactors 
In the culture of many tissues, especially tendon, ligament, bone, skin and vocal fold, 
one of the fundamental properties of the tissue substitute is its ability to resist a mechanical 
strain. Thus, many bioreactors have an actuator to test the tissue resistance towards a 
mechanical strain, but also to induce phenotype changes during cell growth. Titze and 
colleagues built a system based on standard T-flasks with voice coil actuator and vibration bar 
to investigate the effects of tensile strain and vibration on primary cultures of human 
laryngeal fibroblasts [19]. Previous evidences in literature demonstrated significant effects of 
cyclic strain on mesenchymal cells (e.g., up-regulation of elastin [refs. 5,9-10 in [19]], 
hyaluronate [ref. 10 in 20] and proteoglycan synthesis [ref. 5 in 30], ECM reorganization [ref. 
9 in 19]) and on fibroblasts (200-fold increase in matrix metalloproteinase MMP production) 
[ref. 12 in 19]. Their strain/vibrational reactor experiments revealed that strain had a 
significant positive effect on elastin (+), procollagen (+), fibronectin (+) and fibromodulin (+) 
[19]. Moreover, the positive or negative effects of strain combined with vibration were even 
more pronounced on procollagen (-), fibronectin (+), MMP-1 (+), hyaluronic acid synthase 2 
(+), CD44 (+), fibromodulin (+) and decorin (+), compared to cultures carried out with strain 
alone. 
Meyer et al. [20] used a piezoelectric actuator to induce homogeneous deformations of 
cell-containing substrates in predetermined regions of the 3D construct with precise control of 
the strain field. Deformation occurred in one axis, resulting in a biaxial elongation. A 
continuous flow induced by a pump fed osteoblasts or chondrocytes located in the central 
region of the collagen gel. Deformation caused by the actuator resulted in an increase in cell 
proliferation and ECM production in both cell types up to a value of 2000(xstrain. Higher 
loads produced a decrease in cell numbers, suggesting a transitory strain zone between 
positive and negative effects. 
1.5 Examples of commercially available bioreactors for tissue 
engineering 
1.5.1. Rotating bed bioreactor from Z®RP Technology (Glen Mills, USA) 
The Z®RP bioreactor is designed for the growth of adherent cells in 3D environment. 
The scaffold of ceramic-based (each disk has a diameter of 65mm and a thickness of 3mm) 
doped with zirconium oxide, is rotated to pass intermittently through a cell culture medium 
and air. In some aspects, this system is similar to rotating drums used in solid-state 
fermentations [1]. Initially, cells are suspended in the culture medium and over time, they are 
supposed to penetrate the pores of the scaffold. We have some reserve as whether or not 
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sufficient number of cells would penetrate the scaffolds. The system can be autoclavable and 
is offered in volumes of 0.5L or 5L. Also, cells are inoculated with a syringe through a 
septum, allowing multiple inoculations without affecting sterility. 
Diederichs and colleagues successfully cultured human adipose tissues derived from 
mesenchymal stem cells using the Z®RP bioreactor [21]. Using this system, they concluded 
to an increase in cell proliferation, as deduced from glucose consumption and lactate 
production, when compared to controls cultured in static conditions. Furthermore, the Z®RP 
bioreactor has also been tested by RQker et al. to culture human mesenchymal stem cells [22]. 
These authors reported a 47-day culture using a differentiation medium with a continuous 
increase in glucose consumption, lactate production and calcification (after staining). 
The use of such a bioreactor to culture cells at high density in a solid matrix remains to 
be further demonstrated. 
1.5.2. Fixed-bed bioreactor from Medorex and Netv-Brunswick 
Packed-bed (or fixed-bed) bioreactors are common reactors found in the culture of 
mammalian cells because they have been well characterized in the chemical industry in solid 
catalysis. Instead of immobilizing or coating a chemical on a solid support to create a catalyst, 
cells are anchored to or trapped into the bed. Inside the vessel, a constant mixing allows 
feeding the bed for cell requirements. There is also a controller for temperature, pH and DO 
concentration. New Brunswick (Edison, NJ, USA) offers FibraCel scaffold disks as bed for 
their CelliGen bioreactor. In the fermentation industry, fixed-bed fermentors provide low-
foaming and low shear environment. The technology is easily adaptable to fed-batch, batch or 
even continuous systems. Fixed-bed reactors are less common in tissue engineering. 
1.5.3. TheFlexcell Tissue Train Culture System 
This system consists in a modified 6-well plate (9.62 cm2/well) to create uniaxial or 
biaxial cyclic strain to 3D constructs. The principle is based on the flexible bottomed culture 
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plate and the Flexcell Tissue Train® technology that improves strain. Each well can be cell-
seeded in a gel to a matrix-bonded foam that improved cell attachment. The device is 
optically clear and adapted to phase contrast, fluorescence or confocal microscopy; to allow 
the use of such microscopy techniques, very thin constructs have to be considered. Culture 
plates are available with covalently bonded amines, collagen, elastin, RGD and laminin. 
Riboh and colleagues have used the Flexcell technology to test both continuous and 
intermittent cyclic uniaxial strain on epitenon tenocytes, sheath fibroblasts, bone marrow-
derived mesenchymal steam cells and adipo-derived stem cells for the growth of tendons [23]. 
The authors observed a decrease in cell proliferation when using continuous cyclic strain for 
all cell types but they also observed an increase in adipo-derived stem cells proliferation with 
intermittent cyclic strain. The increase in collagen I production was significant only with 
continuous cyclic strain for adipo-derived stem cells, while total collagen production was 
significant only with a specific intermittent cyclic strain. Although perhaps interesting to 
investigate the effect of mechanical strain on cells, this system does not represent a bioreactor 
(based on our definition) and cannot be used to culture tissue mass for subsequent clinical use. 
1.6 Conclusions 
Mammalian tissue growth in reactors is limited by strict requirements such as oxygen, 
nutrient and waste transfer and shear stress. Many types of reactors have been proposed to 
meet these putative requirements, the two most successful arguably being the rotating vessel 
reactors and the hollow fiber reactors. 
As stated before, the main objectives for mammalian tissue growth in reactor conditions 
must be to facilitate nutrient delivery and waste elimination to the center of the tissues. As 
previously discussed [1], the uterus should be a good basis of a model for the in vitro growth 
of mammalian tissues. In fact, if someone wants to construct clinically sized tissues, the 
presence of some sort of circulation within the tissues will be mandatory. If this circulation 
can be established, the placental exchange model could become very valuable to provide 
adequate transfer to the growing tissues. One can ultimately imagine a reactor configuration 
using forced convection through a seeded polymer matrix making the cells align in the 
direction of the flow (thus forming "vessels"), and continuous medium regeneration via a 
placental-like exchange membrane, creating a friendly environment closer to the uterus. 
Most commercially available bioreactors are not well suited to support the growth of 
large tissue mass. Also, many bioreactors reported in the scientific literature are characterized 
in term of unit operations and process conditions, perhaps due to the emergence of this field, 
opening the door to important misinformation and misconception. As such, it is difficult to 
establish the effects of dynamic culture conditions over tissue substitute development and 
function. The use of dimensionless numbers may provide one of the tools to alleviate this 
problem, allowing to rigorously designing, studying and comparing different reactors. 
Unfortunately, the use of sound engineering concepts in some existing reactor configurations, 
such as the bag bioreactor, is almost impossible, reducing the situation to a trial-and-error 
approach for very specific cellular systems. Moreover, one imprecise definition of a 
bioreactor refers to any devices or systems that support a biologically active environment. 
Thus, almost everything responds to this definition of bioreactor, even a yogurt. This has 
often led to confusion on whether or not a system is a bioreactor. 
The implantation of culture protocols involving a bioreactor introduces many 
challenges, often hidden or not addressed in scientific papers. Among these challenges is the 
maintenance of sterility in long-term cultures, the optimization of each unit operation, leakage 
and breakage. Introducing the use of bioreactor system is a challenge not only about biology 
perspectives, but it is rather an interdisciplinary challenge that should involve the application 
of sound engineering approaches. 
So far, the reactors available to support tissue growth do not allow a good control and 
27 
monitoring of the tissue growth (e.g., nutrient and waste concentration). A serious difficulty 
in the culture of engineered tissue constructs, probably as important as tissues and cells 
availability, is the absence of standardized, universally accepted methods that could be 
recommended or prescribed to monitor and control the growth of large tissue engineered 
constructs. This is clearly an area where further research is urgently warranted. 
A major limitation in understanding bioreactor performance to grow tissue-like mass 
lies in our inability to obtain direct information on conditions within the reactor and their 
effect on the biochemistry of the cells. It is very difficult to find inexpensive commercial 
biosensors that can be used to monitor the growth of tissue-engineered constructs. Non­
invasive and non-destructive imaging methods such as PET and MRI are well suited for this 
purpose and should be further developed and validated. 
Seeding cells into scaffolds at high densities is another important aspect that should 
dictate the development of bioreactors for tissue engineering applications. It is a significant 
challenge to distribute a high density of cells efficiently and uniformly throughout a scaffold. 
Cell seeding strategies need to be developed. The use of automated and controlled processes 
can reduce the safety risks associated with the handling and transfer of constructs between 
separate reactors. In addition to create a physiological environment, bioreactors for tissue 
engineering purposes should be used in a closed manufacturing system to allow the seeding of 
cells, as well as the growth, shipping, and storage of the engineered tissue products all within 
the same container, improving the chance to maintain sterility, reducing labor, and 
eliminating the need for repackaging [ref. 1 in 1]. 
1.7 References 
1. Martin Y, Vermette P. 2005. Bioreactors for tissue mass culture: design, characterization, 
and recent advances. Biomaterials 26:7481-7503. 
28 
2. Bilodeau K and Mantovani D. 2006. Bioreactors for tissue engineering: focus on 
mechanical constraints. A comparative review. Tissue engineering 12(8):2367-2383. 
3. Vunjak-Novakovic G, Radisic M and Obradovic B. 2006. Cardiac tissue engineering: 
effects of reactor flow environment on tissue constructs. Journal of chemical technology 
and biotechnology 81:485-490. 
4. Catapano G, Czermak P, Eibl R, Eibl D and P6rter R. 2009. Bioreactor design and scale-
up. In Eibl R, Catapano G, Pdrtner R and Eibl D. Cell and tissue reactor engineering. 1st 
edn., chapter 5., pp 173-259. Heidelberg: Springer. 
5. Chaudhuri J and Al-Rubeai M. 2005. Bioreactors for tissue engineering: principle, design 
and operation. Netherland: Springer. 
6. Kasper C, Van Griensven M and Portner R. 2009. Bioreactor systems for tissue 
engineering. Germany: Springer. 
7. Eibl R, Werner S and Eibl D (2009) Bag bioreactor based on wave-induced motion: 
characteristics and applications. Advances in biochemical engineering/biotechnology. 
115:55-87. 
8. Kilani J and Lebeault J-M (2007) Study of the oxygen transfer in a disposable flexible 
bioreactor with surface aeration in vibrated medium. Applied microbiology and 
biotechnology 74:324-330. 
9. Chouinard JA, Gagnon S, Couture MG, L^vesque A and Vermette P. 2009. Design and 
validation of a pulsative perfusion bioreactor for 3D high cell density culture. 
Biotechnology and bioengineering. 104(6): 1215-1223. 
10. Maes F, Van Ransbeeck P, Van Oosterwyck H and Verdonck P. 2009. Modeling fluid 
flow through irregular scaffolds for perfusion bioreactors. Biotechnology and 
29 
bioengineering. 103:621-630. 
11.Bjork JW and Tranquillo RT. 2009. Transmural flow bioreactor for vascular tissue 
engineering. Biotechnology and bioengineering. 104(6): 1197-1206. 
12. Hutmacher DW and Singh H. 2006. Computational fluid dynamics for improved 
bioreactor design and 3D culture. Trends in biotechnology 26:166-172. 
13. Jaasma MJ, Plunkett NA, O'Brien FJ. 2008. Design and validation of a dynamic flow 
perfusion bioreactor for use with compliant tissue engineering scaffolds. Journal of 
biotechnology. 133:490-496. 
14. Levesque MJ and Nerem RM. 1990. Vascular endothelial cell proliferation in culture and 
the influence of flow. Biomaterials 11:702-707. 
15. Akimoto S, Mitsumata M, Sasaguri T and Yoshida Y. 2000. Laminar shear stress inhibits 
vascular endothelial cell proliferation by inducing cyclin-dependent kinase inhibitor p21 
Sdil/Cipl/Wafl. Circulation research 86:185-190. 
16. Davies PF, Remuzzi A, Gordon EJ, Dewey FC and Grimbrone MA. 1986. Turbulent fluid 
shear stress induces vascular endothelial cell turnover in vitro. Proceeding fo the national 
academy of sciences USA. 83: 2114-2117. 
17. Chiu J-J, Wang DL, Chien S, Skalak R, Usami S. 1998. Effects of disturbed flow on 
endothelial cells. Transactions of the american society of mechanical engineers. 120(1): 2-
8. 
18. Zhang Z-Y, Teoh SH, Chong W-S., Foo TT, Chng Y-C, Choolani M, Chan J. 2009. A 
biaxial rotating bioreactor for the culture of fetal mesenchymal stem cells for bone tissue 
engineering. Biomaterials 20:2694-2704. 
30 
19. Titze IR, Hitchcock RW, Broadhead K et al. 2004. Design and validation of a bioreactor 
for engineering vocal fold tissues under combined tensile and vibrational stresses. Journal 
of biomechanics 37:1521-1529. 
20. Meyer U, BOchter A, Nazer N and Wiesmann HP. 2006. Design and performance of a 
bioreactor system for mechanically promoted three-dimensional tissue engineering. 
British journal of oral and maxillofacial surgery 44:134-140. 
21. Diederichs S, R5ker S, Marten D. Peterbauer A, Scheper T, Van Griensven M, Kasper C. 
2009. Dynamic cultivation of human mesenchymal stem cells in a rotating bed bioreactor 
system based on the Z®RP platform. Biotechnology progress 25:1762-1771. 
22. ROker S, Diederichs S, Stark Y Bdhm S, Ochoa I, Sanz JA, Garcia-Aznar M, Doblare M. 
Van Griensven M, Scheper T, Kasper C. 2009. Novel 3D biomaterials for tissue 
engineering based on collagen and macroporous ceramics. Materialwissenschaft und 
werkstoffetchnik 40:54-60. 
23. Riboh J, Chong K.S. A, Pham H, Longaker M Jacobs C, Chang J. 2008. Optimization of 
flexor tendon tissue engineering with a cyclic strain bioreactor. The journal of hand 
surgery 33:1388-1396. 
31 
CHAPTER 2: FLOW DYNAMICS WITHIN A 
BIOREACTOR FOR TISSUE ENIGNEERING BY 
RESIDENCE TIME DISTRIBUTION ANALYSIS 
COMBINED WITH FLUORESCENCE AND 
MAGNETIC RESONANCE IMAGING TO 
INVESTIGATE FORCED PERMEABILITY AND 
APPARENT DIFFUSION COEFFICIENT IN A 
PERFUSION CELL CULTURE CHAMBER 
Justin Dubois1,2, Luc Tremblay3, Martin Lepage3, Patrick Vermette1,2* 
1. Laboratoire de bio-ingenierie et de biophysique de l'Universit^ de Sherbrooke, 
Department of Chemical and Biotechnological Engineering, Universite de Sherbrooke, 
2500, blvd de 1'Universite, Sherbrooke, Quebec, Canada, J1K 2R1. 
2. Research Centre on Aging, Institut universitaire de g&iatrie de Sherbrooke, 1036, rue 
Belvedere Sud, Sherbrooke, Quebec, Canada, J1H 4C4. 
3. Department of Nuclear Medicine and Radiobiology and Centre d'imagerie moteculaire de 
Sherbrooke, Universite de Sherbrooke, 3001, 12e Avenue Nord, Sherbrooke, QC, Canada, 
J1H 5N4. 
•Corresponding author: 
Department of Chemical and Biotechnological Engineering, Universite de Sherbrooke, 
2500, boul. de 1'University, Sherbrooke, Quebec, Canada, J1K 2R1. 
Phone: 819-821-8000, ext. 62826; Fax: 819-821-7955. 
E-mail: Patrick.Vermette@USherbrooke.ca 
Running title: RTD and MRI study of bioreactor operation. 
32 
2.1 Abstract 
This study reveals that residence time distribution (RTD) analysis with pH monitoring after 
acid bolus injection can be used to globally study the flow dynamics of a perfusion bioreactor, 
while fluorescence microscopy and magnetic resonance imaging (MRI) were used to locally 
investigate mass transport within a hydrogel scaffold seeded or not with cells. The bioreactor 
used in this study is a closed-loop tubular reactor. A dispersion model in one dimension has 
been used to describe the non-ideal behavior of the reactor. From open-loop experiments 
(single-cycle analysis), the presence of stagnant zones and back mixing were observed. The 
impact of the flow rate, the compliance chamber volume and mixing were investigated. 
Intermediate flows (30, 45, 60 and 90 mL-min"1) had no effect over RTD function expressed 
in reduced time (6). Lower flow rates (5 and 15 mL-min"1) were associated to smaller extent 
of dispersion. The compliance chamber volume greatly affected the dynamic of the RTD 
function, while the effects of mixing and flow were small to non-significant. An empirical 
equation has been proposed to localize minima of the RTD function and to predict Per. 
Finally, cells seeded in a gelatin gel at a density of 800,000 cells-mL'1 had no effect over the 
permeability and the apparent diffusion coefficient, as revealed by fluorescent microscopy 
and MRI experiments. 
Keywords: Residence time distribution (RTD); Bioreactor; Magnetic resonance imaging 
(MRI); Tissue engineering; Endothelial cells; Cell density; Micro-channeled gelatin scaffolds. 
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2.2 Introduction 
From the last decades, there has been an emergence in the development and use of 
bioreactors to culture human tissue substitutes. One of the principal challenges that tissue 
engineering is facing is the oxygen supply to large cell and tissue aggregates and waste 
removal from these living assemblies (Martin et al., 2004; Martin and Vermette, 2005). 
Oxygen solubility in cell culture media (i.e., atmospheric pressure, 37°C) is 45 times lower 
compared to in vivo conditions (Martin and Vermette, 2005). To overcome this limitation, 
oxygen carriers (Naruto et al., 2007; Sullivan et al., 2008) or convective forces must be used. 
Convective forces applied simultaneously with mechanical constraints can be used to increase 
oxygen transport within cell aggregates by creating interstitial flow (Bjork and Tranquillo, 
2009). Thus, oxygen mass transfer in tissue is no more solely diffusion dependant and 
hypoxia inside cell pellet can be avoided. Convective mass transport that can be introduced 
and modulated through the use of bioreactors becomes essential to the successful growth of 
large tissue substitutes. In bioreactor culture conditions, phenotypes more related to those 
found in native physiological conditions can be achieved (e.g., cell elongation in flow 
direction) (Davies et al., 1986). However, as previously reviewed (Martin and Vermette, 
2005), bioreactors are often poorly characterized and this may sometimes lead to 
misconceptions. For example, Davies and colleagues showed that for the same shear stress 
level, only disturbed (turbulent) flow induced cell proliferation (Davies et al., 1986). The 
observed cell responses, expected to be related to shear stress level, might not be correlated 
only to shear stress. Then, reproduction of similar experiments in other reactor set-ups could 
lead to completely different cell responses. The characterization of bioreactors and flow 
dynamic with dimensionless numbers is expected to improve our understanding of the 
different bioreactor designs and operation procedures found in literature. 
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Another example of the necessity to understand the flow dynamics within a bioreactor 
for mammalian cell culture is when considering that cells respond to growth factors often at 
low level (nM range) and small deviation (2-3 folds) of growth factor concentration or 
exposure time could switch on/off gene expression pattern (Akeson et al., 2010; Kawamoto et 
al., 1984; Nelson et al., 2008). In the scientific literature, the effects of growth factors are 
almost always investigated under static culture conditions with a growth factor concentration 
specified only at time zero. One of the objectives of dynamic cultures involving the use of a 
bioreactor is to prolong culture time to form larger substitutes and thus, one cannot assume a 
constant concentration over time. Hence, the periodic feeding of a fresh amount of growth 
factors could be required. Before studying the effect of growth factors on cells under 
bioreactor conditions, it becomes necessary to understand the flow dynamics within such 
bioreactors to further introduce and use sound chemical reaction engineering principles. 
We have previously reported the design and validation of a perfusion bioreactor to 
sustain high cell density cultures of human endothelial cells dispersed in fibrin (Chouinard et 
al., 2009). This system can support cell viability and cell proliferation. Here, the same reactor 
system was used with some improvements. The aim was to use residence time distribution 
(RTD) to characterize the bioreactor, as RTD analysis can be applied to a wide range of 
bioreactor designs (Fogler, 2006). The effects over RTD of flow rate, compliance chamber 
volume and mixing inside the compliance chamber were investigated without a cell culture 
chamber. Furthermore, forced permeability and the apparent diffusion coefficient within a 
gelatin-filled culture chamber with and without cells were investigated by fluorescence 
microscopy and MRI, respectively. 
2.3 Materials and Methods 
Materials 
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Culture medium 199 (Ml99, M5017), endothelial cell growth supplement (ECGS, 
E2759), heparin (HI027) and porcine type A gelatin (G1890) were purchased from Sigma-
Aldrich (Oakville, ON, Canada). Antibiotics (penicillin G/streptomycin sulfate (15140-122)), 
L-glutamine (#25030) and FBS were from Invitrogen (Burlington, ON, Canada). 
Bioreactor Set-Up and Operation 
The block diagram of the bioreactor for RTD analysis is presented in Figure 1A. The 
reactor is a closed-loop system consisting of a peristaltic pump (Masterflex Model A-77924-
10, Cole-Parmer, Montreal, Canada), a pump head (Easyload, Model 7518-60, Cole-Parmer), 
a custom-made glass spiral heat exchanger coupled to a heat bath (Haake DC10-P5, Thermo 
Fisher Scientific, Whaltam, MA, USA), a Coriolis mass flow meter (Promass 83A, Endress + 
Hauser Canada Ltee, St-Laurent, Quebec, Canada), two custom-made gas exchangers with 
Tygon® biopharm silicone tubing (cat. # 95702-05, Cole-Parmer), a pH probe (InPro 
3100/120/ptl00, Mettler-Toledo, Columbus, OH, USA), a dissolved oxygen probe (InPro 
6800, Mettler-Toledo), a pH transmitter (2100e, Mettler-Toledo), an O2 transmitter (4100e, 
Mettler-Toledo), a pressure probe (PX4200-005G, Omega, Laval, Quebec, Canada), a 
custom-made housing for pH and DO probes, a pneumatic pulsator (Vermette et al., 1998), 
and three gas flow controllers (M100B00812CS1BV, CCR, Kanata, Ontario, Canada). The 
tubing used to connect the units consists either of Masterflex pharmapure LSI5 (cat. # EW-
06435-15) or fluorinated ethylene propylene tubing (cat. # EW-06450-04) and the pump 
tubing is Masterflex chemdurance-bio LS 14 (cat. # EW-06442-14), all purchased from Cole-
Parmer. Four-way valves are from Smiths medical (Markham, Ontario, Canada, MX5341LN). 
Cell Culture Chamber 
The custom-made cell culture chamber is made from polysulfone and microscope 
slides (Fig. 1C). The chamber is filled with 3 mL of a 15% (w/v) gelatin solution at 37°C that 
was cross-linked by adding 50jiL per mL of gelatin of a 25 U-mL'1 m-transglutaminase 
(mTG). Human umbilical vein endothelial cells (HUVEC) P8 were trypsinized, centrifuged 
(1200 rpm, 5 minutes), suspended in supplemented media (M199 with 2.2 g-L"1 sodium 
bicarbonate, 90 mg-L"1 porcine heparin, lOOU-mL"1 penicillin, 100 (ig mL'1 streptomycin, 
10% (v/v) FBS, 2mM L-glutamine, and 20ng-mL"1 ECGS) and counted by hemacytometer. 
Then, the volume needed to get a final concentration of 8x10s cells-mL"1 was poured in a 
falcon tube prior to a second centrifugation step. Supernatant was removed and cells were 
suspended with gelatin + mTG solution. The liquid solution (gelatin + m-transglutaminase + 
medium (with or without HUVEC)) was then introduced into the cell culture chamber with a 
syringe. Four 20G medical-grade needles (20G x 1.5", cat. #305176, Becton Dickinson, ON, 
Canada) were used to close the four lateral holes of the chamber. The jellification of the 
solution was carried out overnight at room temperature. After jellification, the needles were 
removed from the cell culture chamber to create channels. Two tube adaptors were screwed to 
the chamber to orientate flow within these 4 channels for permeability experiments. 
Residence Time Distribution (RTD) Analysis 
One milliliter of 0.01M HC1 was injected into the system through an injection port 
positioned after the pH probe (Fig. 1A). For single-cycle analysis, the system was not a close-
looped system but rather an open system in which fresh solution was fed in the entrance and 
the solution at the exit was discarded. For multiple-cycle analysis, the reactor was treated as a 
100%-recycle system in which the same volume was circulated in a closed loop. From both 
techniques, pH values were translated into non-logarithmic scale i.e., molar H+ concentration. 
The H+ concentration before injection was set to zero to facilitate mathematical treatment. 
When performing single-cycle experiments, the concentration function of the tracer 
(C(t)) is directly transformed to a dimensionless RTD function (Equation 1) (Fogler, 2006). 
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E(8)-r*E(t ) -  l* C ( t )  [11 
fC{t )dt  
o 
The residence time (r) of a given compound is calculated with the estimated reactor 
volume (148mL in this case) divided by the volumetric flow rate measured by the Coriolis 
mass flowmeter. The integral part of Equation 1, representing the area under the C(t) curve, is 
calculated by a numerical technique. 6 is the reduced time (t/x). 
When performing multiple-cycle analysis, the steady state tracer concentration (Cr,) 
is known. Thus, concentrations recorded following injection are divided by this value 
(Equation 2). This leads to a final steady state value (adimensional) of one unit. 
^r.« 
Mathematically, Equation 1 is the same as Equation 2 (Annex). From single-cycle 
analysis, first and second moments (mean time, tm and variance, (f) of the RTD function are 
calculated with Equation 3. 
00 
tm - J tE(t)dt 
0 
[3 a,b] 
0 
Dispersion Model and the Per to Explain Non-Ideal Behavior 
From single-cycle or multiple-cycle analysis, we hypothesize that one of the main 
parameters affecting the non-ideal behavior, and possibly limiting the fit of our data, is the 
dispersion that broadens the initial impulse (Levenspiel, 1999; Fogler, 2006). Taking mass 
transport equation with no reaction and with dispersion and convection gives (Fogler, 2006): 
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m DabV2Ct - V • (C/Cr) [4] 
at 
where DAB is the "isotropic" diffusion/dispersion coefficient, Cr the tracer 
concentration, and U is the mean molar velocity. The first term of Equation 4 corresponds to 
diffusion, while the second is the convective term. Considering that it is not possible in our 
case to evaluate the tracer concentration over the tubing radius, only the molar average 
velocity in the z-direction is considered. This latter simplification means that the reactor is 
approximated to an ideal plug flow reactor (with no laminar parabolic profile). 
v11 v-' 
—
11 
- D,„ f_lL _ u ^ JL [5] 
dt B dz1 dz 
Equation 5 can be further expressed in terms of dimensionless numbers with the 
following substitutions: y/ =Ct/Ct,, X = z/L, and 6 - t/x. CR» is the tracer concentration at 
time /=oo, z is any distance from the impulse position within the reactor, and L corresponds to 
the characteristic length of the reactor. 
<*i> ^Dab r61 
dB " UL d% ~ dk 
Given that Peclet reactor number Per - UL/DAB, only one unknown parameter 
remains. Here, Per is a dimensionless number that characterizes the flow within the reactor. If 
Per —* 0, there is an important dispersion (i.e., CSTR behavior), while if Per —• ao, there is 
negligible dispersion within the reactor (i.e., plug-flow behavior). By substituting Per into 
Equation 6 and by introducing the perfect impulse function (Dirac delta function (<?)), 
Equation 6 becomes (Levenspiel and Bischoff, 1963): 
«<A<1 [7] 
dd Per dX dX 
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To solve Equation 7, boundary conditions need to be defined. For open-open vessel 
boundary conditions (i.e., diffusion is completely isotropic, without any boundaries), the 
solution is given by Equation 8: 
V(1,0) - Ct{L,1) =J -exp| 
Cr>x 2 jx6/Pe, * 
-(i-e)2 
4 d!Per 
[81 
Levenspiel and Smith (1957) were the first to derive Equation 8. However, the 
mathematical algorithm and the boundary conditions to derive Equation 8 are much more 
detailed in van Der Laan's letter (1958). The solution of this equation can be found in 
Levenspiel (1999) and Fogler (2006). However, this equation is only valid for the first bolus 
measurement i.e., taken at the end of the reactor at distance L. Voncken et al. (1964) has 
adapted the equation for 100% recycle where / and j represent the number of circulations and 
the final number of circulations, respectively (algorithm in Annex). 
-0-of  , / •  a \  Cr(y'L>0 1 v [9] 
40/Per 
Here, Per can be tuned by trial-and-error for both cases (closed-loop or open loop) or 
can be found, from single-cycle analysis, by two different methods. Firstly, Equation 10 can 
be used to approximate Per analytically: 
a2 2Per + 8— 
t2m Pe2r + 4Per + 4 
Or, numerically, Per can be found by least square fitting of non-linear function with 
MATLAB software (version 6.5.0.180913a Release 13, license number 51088, MathWorks, 
USA) (algorithm is available in Annex). 
Finally, to evaluate the RTD profile from multiple-cycle analysis we hypothesized that 
the decay of maxima or the increase of minima peaks of y(9) functions were exponential up 
to the final value of one unit. This assumption yields Equations 11. 
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V«,(0> - l + exp[-«(0-^)] [11 a,b] 
VuW =» 1 - exp[-/5(6> - 6>0 )] 
The introduction of deviation variables was attempted to obtain a better fit. 
a and p are two constants related, respectively, to the exponential damping of maxima 
and minima, while 02X and 6o are the reduced times corresponding to, respectively, a 
concentration twice the final concentration and to a non-zero concentration. According to 
Equation 8 or 9, the use of Equations 1 la,b to fit maxima and minima does not seem relevant 
a priori. The theoretical damping of the maxima of function y/max(Q) is already set with the 
non-exponential term (^====). Equations 1 la,b are used rather than the non-exponential 
term of Equation 8 or 9 because this part does not fit data when the overlapping of the bolus 
becomes significant or for small Per. The equation is only good for some cycles at high Per 
values, then it decreases to 0, instead of 1, at 0 —* oo. 
Forced Permeability Experiments 
A closed system consisting of the cell culture chamber filled with a gelatin gel seeded 
or not with HUVEC, a peristaltic pump and compliance chamber was set-up (Fig. IB). 100 
mL of a rhodamine B solution made in Milli-Q water at a concentration of 2xl0"5 M was 
added to the compliance chamber. The cell culture chamber was tightly fixed to the 
fluorescent microscope. The exposure time was set to 0.001s. Rhodamine B is a fluorescent 
dye that is excited in the green spectrum (540nm), emitting in the red (625nm). The focus was 
made in the visible light using one of the channels of the cell culture chamber at a 4x 
magnification and pictures with both visible light and green light were recorded. Time zero 
corresponds to the time at which the pump is switched on at a flow rate of 60 mL-min"1. The 
experiments were run for 45 minutes. The analysis of the pictures was done using the Image J 
software by selecting a region of interest (ROI) and by analyzing the histogram of the 
spectrum in the ROI. Images were analyzed using the same ROI positioned at the channel 
boundary. Means and standard deviations of the histogram were analyzed to evaluate 
permeability of the gelatin-containing chamber with or without HUVEC. 
Apparent Diffusion Coefficients Measured by MRI 
MRI images were acquired with a 210-mm small-animal 7T scanner (Varian Inc., Palo 
Alto, CA, USA) operating at 300 MHz. A multi-slice diffusion-weight gradient echo 
sequence was used to monitor the effect of cell density on the apparent diffusion coefficient 
(TR = 2000 ms, TE = 25 ms, 1 average, matrix 128 x 128, FOV of 25 mm2, coronal 
orientation, slice thickness = 1mm, 8 = 3 ms, A = 9.5 ms and Gdiff = [0.5, 10, 15, 20] xlO"4 
T/cm). The apparent diffusion coefficient is obtained from 
Where / and lo represent the intensity with or without diffusion gradients, y is the proton gyro-
magnetic coefficient 42.58 MHz/T, S is the duration of the diffusion-weighted gradient 
pulses, A is the delay between two gradient pulses, GJIFF is the gradient intensity, D is the 
apparent diffusion coefficient (ADC) of water. D is the only unknown variable in this 
2.4 Results and Discussion 
Flow Regime Within the Reactor 
The reactor without the compliance chamber can be seen as a long series of tubes of 
different diameters. Larger tubes are necessary to connect units such as the Coriolis mass flow 
meter, valves, heat exchanger, and others. But, to maintain sterility, a long tube is needed to 
connect the cell culture chamber under the laminar flow hood; this tube is smaller to keep the 
equation. As b -  y 2 8 2 G 2 {A -  y j,  b  values used were 0,14,55,123,219,342,460 s/mm2. 
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reactor volume small. Tube diameters vary from 1.6mm to 4.8mm, resulting in Re values of, 
respectively, 1770 and 590 at the highest flow rate tested (90 mL-min'1). For all experiments, 
the regime was theoretically laminar (Re < 2000). Nevertheless, it must be considered that 
even with laminar flow, the flow is disturbed by two 90° elbows, by the geometry of some 
units (i.e., valves, probes and probe support) as well as by tubes of varying diameters. 
Single-Cycle Analysis To Detect Non-Ideal Behavior and Pe, in Open-Loop 
From multiple-cycle analysis, a pulse was found to merge with the next one, leading to 
an incomplete bolus. A complete cycle is required to obtain information on the non-ideal 
behavior of the reactor. Therefore, experiments were carried out in open loop. From Figure 
2A, it is possible to observe that the maximum is not perfectly aligned to the reduced time 
value of one. The pulse is delayed with the function maximum observed at a reduced time 
value of 1.09. This can be explained by the open-open boundary conditions that can lead to 
strong back mixing (i.e., tracer can diffuse back in the system). Moreover, the presence of a 
long tail indicates stagnant zones, which would result in a pulse occurring before a reduced 
time of one unit. Thus, owing to the counter effect of stagnant zones, the delay caused by 
back mixing is possibly more pronounced than observed in Figure 2A. By using Equation 10, 
Per is calculated yielding a value of ca. 9. When this value is inserted into Equation 8 and 
then compared with the experimental data, the fit was weak (sum of squares of 38) (Fig. 2B). 
Note that Equation 8 has been re-centered at a reduced time of 1.09 by changing the unit 
value of the exponential term and by multiplying equation by the same factor for all graphs. 
Doing directly the least-square fitting of Equation 8 (algorithm in Annex) with Matlab gives a 
Per of 50 with a sum of squares of 23. Because Equation 8 does not consider non-ideal 
behaviors other than dispersion, to increase the precision of the Matlab fit, more importance 
has been given to the first 2/3 of the bolus to reduce the effect of the non-ideal behavior (i.e., 
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the stagnant zone). This leads to a much better fit compared to Equation 10 (Fig. 2B). 
Manually, it is also possible to fit a Per, allowing to discard the contribution of the stagnant 
zones. Nevertheless, if the result is good, it gives a larger sum of squares since the minimum 
has already been found by least square fitting (LSQ). Sum of squares with manual fitting of 
Per gives 25 with Per=70 (Fig. 2B). 
All the values of Per calculated with the single-cycle analysis are below 100 and 
correspond to a system with large deviations from a plug flow. Basically, with such a low 
value, this means that the response (bolus) is affected by the time required for a complete 
measurement, leading to a more asymmetrical curve. 
Multiple-Cycle Analysis To Detect Non-Ideal Behavior and Per in Closed-Loop 
Per Evaluation with Multiple-Cycle Analysis 
The above methodology was applied to a closed-loop system. Equation 9 is also re-
centered and the non-exponential term multiplied by the delay factor. Per found by Matlab 
(Per=50) was used (Fig. 3). However, the equation was realigned to 1.145 instead of 1.09. 
This deviation is probably caused by the extent of back mixing, underestimated by the 
stagnant zone in the single-cycle analysis. This may be amplified at longer times. Figure 3 
confirms the exactitude of the dispersion model to predict experimental data. The fit is almost 
perfect except for the first bolus. 
Effect of Flow rate, Compliance Chamber Volume and Stirring 
The data of Figure 4A suggest that the flow rate does not affect the evolution of the 
normalized concentration for flow rates of 30, 45, 60 and 90 mL-min'1. The amplitude of the 
first peak appears to be higher at the lower flow rate, although this difference is quite small. 
Further reducing the flow rate leads to larger differences. At a flow rate of 15 mL-min"1, the 
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global difference is significant. Also, the difference is large between 5 mL-min"1 and 15 
mL-min'1 (Fig. 4B). It appears that over a threshold value where disturbed flow is present, Per 
is independent of the flow rate. Decreasing the flow rate under this value leads to larger Per 
i.e., higher peaks magnitude, higher extent of back mixing and a more oscillatory behavior. 
The effect on RTD of the compliance chamber filled with different volumes has been 
investigated. This unit operation was not used in previous experiments. The compliance 
chamber in this bioreactor prevents bubbles to block channel(s) within the cell culture 
chamber (Fig. 1C) and allows volume variation during an injection without drastic pressure 
changes. It consists of a short straw to introduce the medium, a long straw that reach the 
bottom of the chamber for pulling the medium back into the system and a filter positioned at 
the top to avoid excess pressure. For RTD analysis, this unit can be seen either as a small 
continuous reactor in series with a tubular reactor or as a dead volume within the tubular 
reactor. The impact of the compliance chamber was evaluated for volumes of lOOmL and 
200mL (Fig. 5) with or without mixing. The compliance chamber volume has a bigger impact 
compared to flow rate and mixing. Again, two flow rates (30 mL-min'1 and 60 mL-min"1) 
were tested and no significant differences were found. However, the maximum peak of the 
function at the first passage is still higher at the lower flow rate as observed without 
compliance chamber. The mixing, created by a magnetic stirrer, does not have a significant 
impact for the two volumes tested (lOOmL and 200mL), as the two curves overlapped (Fig. 
5). Since the configuration of the compliance chamber pulls liquid from the bottom of the 
vessel, the geometry and particularly the height of the liquid becomes important. Since 
mixing had no effect for a volume of 200mL, we hypothesize that the solution was 
homogeneous when the tracer exits the compliance chamber. 
Evaluating the effect of flow rate, compliance chamber volume and stirring is complex 
to achieve for multiple-cycle analysis since the equation is adapted only for a tubular reactor. 
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This assumption is not valid when the compliance chamber is filled with a given volume. In 
addition, manually fitting the data with an equation such as Equation 9 would be difficult to 
justify. Recirculation increases the risk of errors since an emphasis on the first or the last 
cycles would considerably change the parameter values. 
We attempted to quantify RTD with Equations lla,b, but not only based on Per but 
rather on specific characteristics (a, /?, 02X, do) of RTD curves. Figure 6 compares the 
effectiveness of Equations 11 to predict maxima and minima of Equation 9 for small and 
large extents of dispersion. The equation correlates perfectly for a RTD function with a large 
extent of dispersion. The fit is not as good with a low level of dispersion (high Per) for the 
maxima (Equation 11a) but the function with minima is better (Equation lib). Thus, the 
parameters of Equation 1 lb are reported in Table 1 for the curves depicted in Figure 6. Note 
that relationship between P and Per is also shown in Figure 6B. 
' to ,  IP ,  1  e^and J0 O — JPe r  
Equation 11 numerically transposes the qualitative conclusions of RTD shifts. Thus, 
the largest effect i.e., that of the compliance chamber volume (lOOmL), is exposed. 
Unfortunately, when the compliance chamber was filled with 200mL, the number of minima 
was not sufficient to find the parameters. Thus, Equation lib can quickly give a close 
approximation of Per and pinpoint the most influent parameters. 
Fluorescent Microscopy and MRI Can Be Used To Investigate Forced Permeability and 
Apparent Diffusion Coefficient Into The Gelatin-Filled Cell Culture Chamber 
Based on personal experience, one of the biggest challenges in growing a cell network 
in a large matrix is to assess the presence of cells without disturbing the experiment. Although 
useful to characterize RTD of the overall bioreactor system, the pH probe was not sensitive 
enough to monitor such small contributing volume (data not shown). Furthermore, impulse of 
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an acidic solution into the culture chamber with cells might not be a viable technique for 
further in situ investigation, as the impulse of acid could affect cell function and even viability 
and tracer will not be inert with gelatin. A non-invasive, non-destructive, and sensitive 
technique is needed to investigate, in real time, medium perfusion within the cell-seeded 
culture chamber. The scope behind the forced permeability experiments and MRI experiments 
was to study permeability and apparent diffusion coefficient within the cell culture chamber 
filled with gelatin with and without cells. 
Despite an important visual difference between gels with and without HUVEC (Fig. 
7A), the analysis of the histogram reveals no differences between the two experiments, based 
on the intensity shift of the percolating fluorescent probe in the ROI (Table 2). This finding 
indirectly indicates that the gel permeability is the same. At.8 x 10s cells-mL"1 and 
considering that cells would have a spherical shape with a 40-jun diameter, the fraction of the 
gel occupied by cells is less than 2.7 % (v/v). The cell density used here (0.8 x 106 cells-cm"3) 
is only a fraction (0.16%) to that found in vivo (5 x 108 cells-cm"3) (Rasidic et al., 2007). It is 
possible that the seeded cell density was not sufficient to allow detection. However, based on 
personal experience it is nearly impossible to seed at a density similar to that encountered in 
vivo, while keeping cells alive and being able to have a representative (i.e., of similar 
properties) control gel with no cells. One other possible hypothesis is that convection might 
be too elevated at this flow (60 mL-min'1) to observe a significant difference. 
Apparent diffusion coefficients of gelatin gels seeded or not with HUVEC have been 
investigated to determine whether or not cells, at the seeding step, could be detected by MRI. 
Using this technique, there was no convection contribution; measurements were directly 
related to gel properties. The experiments have been performed directly into the cell culture 
chamber (data not shown) and into an Eppendorf tube (Fig. 7B) containing a gelatin gel 
similar to that previously described. Analysis was carried out in Eppendorf tubes because the 
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paramagnetic properties of air (oxygen) inside the channels affect the signal at the channel 
boundary. The ADC was approximately 2.2 x 10"3 mm2 s"' without significant effect of the 
cells. Plotting the signal intensity against b values resulted in a straight line. Different ADC 
values in the sample corresponding to extracellular and intracellular water would have 
resulted in a graph with two linear portions. As the measured ADC in the gel is close to that 
of bulk water, our measurements are highly dominated by the extracellular water, which is 
found in high proportion in our gel samples considering the number of cells used. 
Overall, fluorescent microscopy and MRI were successfully used to investigate forced 
permeability and apparent diffusion coefficients directly within the cell culture chamber filled 
with gelatin, but the effect of cells over these two parameters was not significant, probably 
owing to the fact that cell density was too low. 
Other techniques such as computational fluid dynamics (CFD) (Maes et al., 2009), 
positron emission tomography (PET) (Kofidis et al., 2003), and computed tomography (CT) 
(Maes et al., 2009; Porter et al., 2007) can be used as alternative to RTD analysis to 
characterize flow dynamics and cell cultures. However, often CFD relies solely on 
development and/or simulation of theoretical models using numerical methods and several 
ideal assumptions rather than on experimental data. PET and CT scans are used in clinics and 
animal studies, although some efforts are being made to adapt medical imaging techniques 
and protocols to the monitoring of cell and tissue cultures (Dubois et al., 2011; Chouinard JA, 
Rousseau JA, Proulx P, Vermette P, Lecompte R. 2009. Monitoring 3D high cell density 
cultures by non-invasive and non-destructive medical imaging techniques. 2009 World 
molecular imaging congress. September 23-26, 2009. Montreal, Qc, Canada; Chouinard JA, 
Rousseau JA, Beaudoin J-F, Vermette P, Lecompte R. 2010.18FDG PET signal optimization 
in vascular cells: a first step toward bioreactor cultures monitoring. 2010 World molecular 
imaging congress. September 8-11,2010. Kyoto, Japan). 
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2.5 Conclusions 
The goal of this study was to describe flow dynamics within a bioreactor designed for 
tissue engineering applications. From single-cycle experiments, the presence of a non-ideal 
behavior, such as stagnant pockets and back mixing, was observed. We tested the 
performance of a new equation to predict maxima and minima of the y(9) function with 
overlapping bolus. The equation for minima with high and low extents of dispersion yielded 
good fits compared to that for maxima, which provided an acceptable correlation only for 
high levels of dispersion. The impacts of flow rate, the compliance chamber volume and 
stirring were investigated. For intermediate flow rates (30 to 90 mL-min'1), the difference was 
not significant. However, at low flow rates (5 and 15 mL-min"1), a different trend was 
observed allowing us to conclude that lower flow rates decreased the level of dispersion. The 
compliance chamber volume greatly affected the RTD function, while mixing had little 
(lOOmL) to no impact (200mL) over RTD. Fluorescence microscopy and MRI were 
successfully used to investigate forced permeability and apparent diffusion coefficient within 
the gelatin-filled cell culture chamber. However, forced permeability experiments showed no 
difference between the cell culture chamber filled with a cell-seeded gelatin gel and that filled 
with a cell-free gelatin gel. The MRI technique was not sensitive enough to detect initially 
seeded cells. 
This study reveals that RTD analysis with pH monitoring after acid bolus injection can 
be used to globally study the flow dynamics of bioreactors, while fluorescence microscopy 
and MRI were used to locally investigate mass transport within a hydrogel scaffold seeded or 
not with cells. Given the currently available in vitro culture techniques, it remains a challenge 
to seed cells in gels at a higher density, which would correspond to an order of magnitude 
above that used in this study. It remains to be tested whether or not MRI can be used to 
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monitor more mature cell cultures corresponding to higher cell densities resulting from cell 
proliferation. 
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2.8 Tables 
Table I: ft and 0, parameters of Equation 11 for the different conditions tested. 
(  o m l i t i o n s  
5 mL-min"1 0.6 1.4 
15 mL-min"1 0.6 1.2 
30 mL-min"' 0.8 1.2 
45 mL-min"1 0.8 1.2 
60 mL-min"' 0.7 1.2 
90 mL-min"' 0.7 1.2 
30 mL-min"', Vcc=100mL 2.0 0.88 
60 mL-min'1, Vcc=100mL 2.0 0.67 
30 mL-min"', Vcc=100mL + mixing 2.6 0.77 
30 mL-min"', Vcc=200mL N.A. N.A. 
60 mL-min"1, Vcc=200mL N.A. N.A. 
60 mL-min"1, Vcc=200mL + mixing N.A. N.A. 
N.A.: Not available because not sufficient number of points. 
Vcc'- Compliance chamber volume. 
Table 11: Mean intensities of ROI measured during forced permeability experiments. 
Mean Std 
Without cells 81.4 ±3.2 10.1 ±0.4 
With cells 82.2 ± 1.8 10.3 ±0.1 
Intensity ranging from 0-255. 
2.9 Figure captions 
Figure 1: A) Block diagram of the bioreactor system for RTD analysis. Note that the 
injection port for the impulse is positioned just after the pH probe. B) Block diagram of the 
system for forced permeability experiments. C) Drawing of the cell culture chamber. 
Figure 2: A) Single-cycle analysis after impulse injection at 60 mL-min"1. The reactor was 
operated in an open-loop to avoid overlapping of the tail of the first passage with the front of 
the next one. B) Single-cycle analysis with dispersion model at 60 mL-min"1 (open-loop 
configuration). Data are compared with Equation 8 with Pe, calculated from Equation 10 
(Per=9), least square fitting (LSQ) (Per=50) and manual trial-and-error fitting (Per=70). 
Figure 3: Multiple-cycle analysis with dispersion model at 60 mL-min"1 operated in a closed-
loop configuration. Data are compared with the model of Equation 9 with Per = 50. 
Figure 4: Effect of A) intermediate and B) low flow rates on RTD function with multiple-
cycle analysis. 
Figure 5: Effect of flow rate, compliance chamber volume and mixing over RTD function 
with multiple-cycle analysis. 
Figure 6: Equations 1 la,b to predict maxima and minima of Equation 9 with A) Per=50, B) 
Per=500 with relationship between f) and Per. 
Figure 7: Forced permeability and diffusion in the cell culture chamber. A) Forced 
permeability measured by rhodamine B and B) apparent diffusion coefficient measured by 
MRI. 
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2.10 Annexes 
A- Mathematical Demonstration of >ft(0) and E(0) 
Single - cycle analysis 
g (0- , C ( 0  HI 
/ C(t)dt 
0 I I yi Y 
By combining [2] in [1], 
vC(t) E(t)> 
M 
e{d) - t* e(o-— 
v M M 
Multiple - cycle analysis 
.i, C(t) • r M V>--pr-<CTo~-t 
'-TO V 
VC(t) y,m 
M 
B- MATLAB Algorithm for LSQ Fitting 
Part I- filename cyclel 
global data; 
data=[temps,yl]; 
temps=data(:,l); 
yl=data(:,2); 
plot(temps,yl,'b,); 
hold on; 
estimates0=[60]; 
estimates=lsqnonlin(@cycle 1 suite,estimatesO,1,200); 
fittage = 1.09./(2.*(pi.*temps/(estimates(l))).A0.5).*exp(-l.*(1.09-
temps).A2./(4.*temps/estimates( 1))) 
plot(temps,fittage,V); 
Part II- filename cyclelsuite 
function y=cycle 1 suite(estimates); 
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global data; 
temps=data(:,l); 
yl=data(:,2); 
fittage=l .09./(2.*(pi.*temps/(estimates(l ))).A0.5).*exp(-1 .*( 1.09-
temps). A2./(4. *temps/estimates( 1))) 
y=flttage-yl; 
C- MATLAB Algorithm for Multiple-Cycle Analysis (Equation 9) 
for jj—1:1:50; 
for zz=l: 1:2500; 
P(zz,l)=zz/50; 
C(zz jj)= l/(2*(pi*P(zz, 1)/300)A0.5)*exp(-(jj-P(zz, 1 ))A2/(4*P(zz, 1)/300)); 
end 
end 
for aa=l: 1:2500; 
Y(aa, 1 )=sum(C(aa,:)); 
end 
plot(P,Y) 
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Figure 5 
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3.1 Abstract 
This paper reports the optimization of a perfusion bioreactor system previously described by 
us (Chouinard et al. 2009). The system presented here is operated with a novel micro-
channelled cell culture chamber to support microvessel development. The implementation of 
a proportional and integral (PI) controller algorithm to control oxygen concentration and pH 
is presented and discussed. P and / values used by the controller were first estimated using 
Matlab Simulink model (FOPDT) and then tuned manually. A new gas exchanger design 
compatible with the PI controller was introduced and validated to avoid interaction between 
the injected gases. The gas exchanger is used to adjust both pH and dissolved oxygen 
concentration. This new bioreactor system allowed real-time PI control over pH and dissolved 
oxygen concentration at different flow rates (from 2 to 70 mL min"'). Cell culture experiments 
were used to validate the updated bioreactor design and performance. 
Keywords: Tissue engineering; controller algorithm; pH and dissolved oxygen concentration 
control; microvessel; perfusion bioreactor, micro-channelled scaffold; endothelial cells and 
cell attachment. 
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3.2 Introduction 
In nowadays, the fabrication of human organ and tissue substitutes remains an 
important challenge for the biomaterials community. Traditional ways to culture cells on flat 
surfaces are not able to provide fully functional and usable organ and tissue substitutes. To 
construct organ or tissue substitutes, one has to design good perfusion system able to provide 
constant nutrient supply and waste removal. Bioreactors are regarded as a promising solution 
for the 3D construction of organ and tissue substitutes since they can maintain optimal in vitro 
cell culture environment (Martin and Vermette 2005; Wang et al. 2005). 
There have been many reports on different types of bioreactors including Petri dish 
reactor, pulsative flow perfusion bioreactor, hollow fibre reactor, air lift reactor and others 
(Dubois and al. in press; Martin and Vermette 2005; Wang et al. 2005). Most of the available 
reactors to support tissue growth do not allow control and monitoring of the cultures. An 
important limitation in the culture of tissue substitutes is the absence of standardized, 
universally accepted methods that could be recommended or prescribed to monitor and 
control their growth (Dubois and al. in press). Among reported bioreactors, pulsative flow 
perfusion bioreactors attract considerable interest since they are able to provide ideal 
conditions for cell growth coupled with mechanical stimuli. Mechanical stimuli provided by 
bioreactors are important factors since they are able to promote cell growth and enhance the 
permeability of 3D constructs (Niklason et al. 1999; Xu et al. 2008; Zhang et al. 2008). For 
instance, Xu et al. reported on the engineering of large (6mm in diameter) muscular vessel 
wall using a pulsative flow perfusion bioreactor (Xu et al. 2008). The authors demonstrated 
that, in the presence of pulsative stimuli, the obtained constructs consisted of well-oriented 
smooth muscle cells and collagenous fibers, and possessed better biomechanical properties 
over that obtained without pulsative stimuli. Zhang et al. (Zhang et al. 2008) engineered a 
pulsative flow perfusion bioreactor to mimic physiological conditions. The authors 
demonstrated that a pulsative flow facilitated the formation of a shear-resistant confluent 
endothelium. Despite having numerous reports on the positive effect of pulsative flow, the 
mechanisms behind this phenomenon are still not clear and remain to be elucidated. 
Although mechanical stimuli were recognized as important factors in cell culture, a 
good bioreactor should also be able to provide an acceptable control over pH and dissolved 
oxygen (DO) concentration in culture medium. While physiological blood pH is more or less 
constant (7.4) in human body, oxygen concentration is more susceptible to large variations. 
For instance, oxygen concentration in arterial blood is 130pM (4.16mg/L) and 54^M 
(1.73mg/L) in venous blood (Fournier et al. 1998). However, this represents dissolved oxygen 
concentration in blood and do not consider the amount carried and delivered by the 
hemoglobin. The total oxygen content is two orders of magnitude higher considering the 
protein carrier (Rasidic et al. 2007). Oxygen consumption rate is strongly cell-line dependent. 
Oxygen consumption rate ranges between 64 to 300 pM Orlf'-lO^cells for, respectively, 
human skin fibroblasts and liver cells (Fleischaker et al. 1981). 
Based solely on diffusion, oxygen mass transport can support cell viability to 
distances around lOO^m (Vander et al. 1985, Rasidic et al. 2007). With dynamic environment, 
convective flow significantly increased oxygen concentration within construct/scaffold, 
improving tissue properties and hence viability (Rasidic et al. 2005). It has been shown that 
low IX) level in cell culture medium induces hypoxic conditions followed by the release of 
angiogenic growth factors (VEGF, vWF), which can subsequently promote blood vessel 
formation (Antonova et al. 2008, Rasidic et al. 2007, Schuerer-Maly et al. 1995). Also, 
collagen type I showed a significant decrease at low O2 tension (5%) (Das et al. 2009). Local 
O2 concentration (normoxic/hypoxic) in bioreactor experiments influences the cell 
metabolism and important functions such as adhesion, inflammation, protein synthesis rate, 
proliferation, etc. 
68 
pH of cell culture media can have a very strong effect over the number of viable 
endothelial cells and on the glutatione redox cycle caused by a decrease in intracellular 
reduced glutathione (GSH) content, glutathione peroxidase GPO and glutathione reductase 
activity (Ikebuchi et al. 1993). It has been shown that acidic media (pH 6.4) decreases type I 
collagen, transcription factor SOX9 and VEGF gene expression compared to traditional pH 
(7.4) used in the culture of chondrocytes (Das et al. 2009). Also, glucose consumption and 
lactate production decreased in acidic media for chondrocyte and HL60 cells (Das et al. 2009, 
McDowell and Papoutsakis 1998). Das and their colleagues showed that aggrecan, collagen 
type II and H1F1A are pH dependant. A decrease in extracellular pH also resulted in a 
decrease in CD 13 receptor and in the size of the HL60 cells (McDowell and Papoutsakis 
1998). 
There are some indications in the scientific literature showing that pH and oxygen 
should not be considered as two individual parameters but rather as two parameters with a 
strong interaction. For example, acidic conditions can impair the active oxygen degradation 
and induce further cell dysfunction (Ikebuchi et al. 1993). Moreover, hypoxic conditions (in 
vivo/in vitro) are associated to an acidification of the extracellular medium and re-
oxygenation is followed by re-alkalization of the surrounding medium. Moderate acidification 
is able to protect cells against ischemia while re-oxygenation can enhance their damage 
(Antonova et al. 2008). More precisely, Antonova and their colleagues showed that 
hypoxia/re-oxygenation stimulates pro-inflammatory activation and apoptosis of endothelial 
cells and that extracellular pH influences both processes. Therefore, a polyvalent bioreactor 
should be able to provide mechanical stimuli and keep pH and DO concentration to setpoints 
to study and control these parameters. 
Unfortunately, most of the reported designs of pulsative perfusion bioreactors for 
tissue engineering applications employed traditional laboratory incubators to maintain pH and 
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DO concentration at physiological conditions (Bulick et al. 2009; Hahn et al. 2007; Jeong et 
al. 2007; Kelm et al. 2010; Xu et al. 2008; Zhang et al. 2008). And as a result, the 
experiments conducted with such bioreactors are limited to a pH value of ca. 7.4 and a DO 
concentration of approximately 8 mg L"1 (dissolved oxygen concentration within the culture 
medium under atmospheric conditions). Furthermore, systems requiring the use of incubators 
to compensate pH changes and to adjust DO concentration are highly immobile, since they 
are confined within an incubator to maintain selected CO2 and O2 pressures. One of the 
possible solutions for this limitation would be to implement controllers (e.g., P, PI, PID, PD) 
to regulate flow rates of CO2 and O2 into a gas exchanger, and thus to adjust pH and £>0 
concentration to desired setpoints (Riggs 1999). To the best of our knowledge, there is no 
report on pulsative perfusion bioreactor where important physiological parameters, such as 
pH and DO concentration are modulated using a controller algorithm. 
Our group has recently reported on the design of a new pulsative flow perfusion 
bioreactor (Chouinard et al. 2009). The reported bioreactor is able to control important 
physiological parameters, such as pH, flow and DO concentration at levels allowing 
maintaining 3D high cell density cultures and stimulating massive cell proliferation. In the 
present paper, we report necessary design optimization to our previously reported design 
(Chouinard et al. 2009). Firstly, this article aimed at implementing a system to provide robust 
control over pH and DO concentration in the bioreactor system. A new gas exchange unit was 
introduced to enable the use of a PI control over CO2 and O2 transfer into the system. 
Secondly, this work presents improvements done to enhance sterility of the system. Finally, 
this updated bioreactor was operated and validated with a novel micro-channeled cell culture 
chamber to support cell attachment and viability, as a first step to grow mature oriented 
microvessels. 
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3.3 Materials and Methods 
Materials 
Culture medium 199 (M199, cat.# M5017), HBSS (cat.# H6136), endothelial cell 
growth supplement (ECGS, cat.# E27S9), heparin (cat.# HI027), porcine type A gelatin (cat.# 
G1890-500g) and bovine serum albumin (BSA, cat.# A7906) were purchased from Sigma-
Aldrich (ON, Canada). DAPI (cat.# D1306), goat anti-rabbit alexa fluor 555 (cat.# A21428), 
goat anti-mouse alexa fluor 555 (cat.# A21422), antibiotics (penicillin G/streptomycin sulfate 
(cat.# 15140-122)), L-glutamine (Cat.# 25030), CFSE (cat.# CI 157), phalloidin-red TRITC 
(cat.# R415) and foetal bovine seum (FBS, cat.# 12483020) were obtained from Invitrogen 
Canada (Burlington, ON). Sodium bicarbonate (cat.# SX0320-1) was provided by EM science 
(Gibbstown, NJ, USA). Human umbilical vein endothelial cells (HUVEC, cat.# CI2203) were 
purchased from Promocell (Heidelberg, Germany). m-Transglutaminase (Activa™) was a gift 
from Ajinomoto Food Ingredients LLC USA (Chicago, IL. Human plasma fibronectin (cat.# 
FCOlO) and 0.22jun syringe filters (cat.# SLGP033RS) were obtained from Fisher Scientific 
Canada (ON, Canada). Gas cylinders with CO2 (cat.# GP-700500) and O2 (cat.# GP-529005) 
were provided by Praxair Canada (Sherbrooke, QC). Medical grade needles (cat.# 305176) 
were purchased from Becton Dickinson Canada (Mississauga, ON). Saponin (cat.# 47036) 
and the live/dead assay (cat.# 04511) were purchased from Fluka Canada (ON, Canada). 
Glycine (cat.# G46-1) was ordered from Fisher Scientific Canada (ON, Canada). Mouse mAb 
vinculin (cat.# ab 18058), rabbit pAb eNOS (cat.# ab66127) were purchased from Abeam 
(Cambridge, MA, USA). Cidex Plus 28 Days Solution and Cidezyme soap were provided by 
Dismed Canada (Anjou, QC). 
Bioreactor Design 
The bioreactor design is shown in Figure 1. It consists of a peristaltic pump 
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(Masterflex Model A-77924-10, Cole-Parmer (Vernon Hills, IL, USA)) equipped with a 
pump head (Easyload, Model 7518-60, Cole-Parmer), a 0.5L jacketed vessel (see Fig. 1 (2A)) 
(Model: CG-1926, Chemglass (Vineland, NJ, USA)) with an in-house made lid (note: this 
vessel serves as a housing for pH (Model InPro 3100/120/ptl00, Mettler-Toledo 
(Mississauga, ON, Canada)) and O2 (Model: InPro 6800, Mettler-Toledo) electrodes), two 
transmitters (Models: pH 2100e and O2 4100e, Mettle Toledo), a thermostat (Model Haake 
DC10-P5, Thermo Fisher Scientific, Whaltam, USA), a Coriolis mass flowmeter (see Fig. 1 
(2D)) (Model Promass 83A, Endress + Hauser, Burlington, ON, Canada,), two in-house built 
gas exchangers with Tygon® biopharm silicone tubing (see Fig. 1 (2B-2C)) (cat.# 95702-05, 
Cole-Parmer), a pneumatic pulsator (see Fig. 1 (2E)) (FESTO, Mississauga, ON, Canada) 
(Vermette et al. 1998), three gas flow controllers (cat.# M100B00812CS1BV, CCR, Kanata, 
ON, Canada), a pressure probe (see Fig. 1 (2F)) (Model PX4200-005G1, Omega Engineering, 
Laval, QC, Canada,) and 4-way valves (MX5341LN, Smiths Medical, Markham, ON, 
Canada,). Computer with a multifunction data acquisition board (NI PCI-6229, National 
Instruments, Austin, Texas, USA) and a graphic programming software (LabVIEW 2009, 
National Instruments) were used to control the bioreactor operation. Prior to any experiment, 
the bioreactor was first clean with Cidezyme soap and then sterilized with Cidex Plus 28 Days 
Solution. The detailed sterilization protocol for this bioreactor is shown as supporting 
information. 
pH and O2 Electrodes 
Prior to any bioreactor experiment, the pH electrode was calibrated with three 
standard buffer solutions (pH4, pH7 and pHIO). The O2 electrode was calibrated using 
standard with known oxygen concentration in air-saturated deionized water. 
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Gas Exchanger Unit 
The new gas exchanger design is shown in Figure 1 (2B-2C). The function of this unit 
is to enable control over pH and DO level in the circulating medium. It consists of a 
thermoplastic (Ultemtm) chamber and semi-permeable tubing allowing diffusion of CO2 and 
O2. The mass flow meter provides PI controlled flow rates of O2 or CO2 to compensate pH 
changes and/or to keep DO concentration at selected setpoints in the circulating medium. 
Compliance Vessel Housing pH and O2 Probes 
The jacketed vessel (see Fig. 1 (2A)) used in this bioreactor has multiple functions. 
The double jacket is connected to a thermostat to keep temperature of the circulating medium 
at 37°C. In addition, this vessel serves as a bubble trap and as an electrode housing allowing 
significant simplification of the bioreactor design, therefore enhancing sterility over longer 
culture periods compared to the previous setup (Chouinard et al. 2009). 
Labview Routine and PI Controller 
The constant monitoring and acquisition of the culture parameters is done by a 
Lab VIEW routine that collects and records at regular intervals temperature, flow rate, 
pressure, pH, and DO concentration. The LabVIEW routine also regulates pH and DO 
concentration levels to selected setpoints by the use of mass flow controllers and PI 
algorithms. 
PI Tuning 
MatLab Simulink Experiments 
The P and / values were first estimated using MatLab Simulink. The Simulink model, 
based on a FOPDT (first order process plus dead time), is shown in Figure 2A. Flows of CO2 
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and O2 into gas exchangers were identified as input variables, and pH and DO concentration 
were identified as output variables. Two decouplers (see Fig. 2A) were introduced to diminish 
possible counteraction of controllers in the system. Dead time (denoted as rj), time constant 
(denoted as TP) and gain (denoted as Kp) were determined analyzing open loop dynamic 
response (Riggs 1999) of our bioreactor. To obtain pH open-loop dynamic response, the 
experiment was conducted as follows. The compliance vessel was filled with 250mL of un-
supplemented Ml99 medium under sterile conditions. The system was thermo-stated at 37°C. 
The air flow rates into the gas exchangers were set manually at 100 mL-s"'. Upon setting the 
CO2 flow at 100 mL-s"1, pH values were recorded every 2 seconds until saturation point. The 
O2 open-loop dynamic response experiment was conducted using the same methodology. A 
maximal overshoot of 20% and the speed of stabilization were the selection criteria. The 
decoupler constants (rp) were determined as follows. The air flow rates in the gas exchangers 
were set at a value of 100 mL-s"1. After setting the CO2 and O2 flows at 100 mL-s"1, pH values 
and DO concentration were measured every 2s until a saturation point was reached. 
Manual Tuning 
The manual tuning of the PI controllers was based upon a trial-and-error selection of 
the / values. The P value given by Simulink remained constant. The / value was selected in 
such way that a maximal overshoot of ca. 20% for pH and DO concentration levels was 
observed. 
Endothelial Cell Seeding Within the Micro-Channelled Culture Chamber 
The custom-made cell culture chamber is made from polysulfone and microscope 
slides. It consists of one entry and one exit for gel loading. On its side, four holes allow to 
insert needles to create channels after jellification. The total volume of gel needed to fill the 
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cell culture chamber is less than 2mL. The micro-channelled cell culture chamber is presented 
in Figure 3. 
Prior to cell seeding, the disassembled cell culture chamber (Fig. 3B) was autoclaved 
and assembled under sterile conditions. Thereafter, four 20G medical-grade needles were 
inserted into the chamber to create channels (Fig. 3D). Three milliliters of the gelatin solution 
(15% w/v) at 50°C were mixed with 150|iL of a m-transglutaminase (mTG) solution (25 
U-mL'1). The obtained solution was injected into the chamber using a 3mL syringe (Fig. 3E). 
A 200nm syringe filters were used to remove excess of the air and maintain sterility of the 
chamber. The chamber filled with gelatin solution was left overnight under sterile conditions 
to allow sufficient time for the jellification. Thereafter, needles were removed and two tube 
adaptors were connected to the chamber to provide flow within the channels (Fig. 3C). 
A fibronectin solution made in HBSS (25jig-mL"1) at 37°C was slowly injected into 
the chamber channels using a syringe and left for one hour. Fibronectin has six modules of 
gelatin-binding domain (Katagiri et al. 2003). The excess of fibronectin was washed away 
with HBSS. Thereafter, HUVEC suspended at a density of ca. 5x10s cells-mL'1 in a 
supplemented Ml99 medium and pre-stained with CFSE were injected using a syringe to fill 
the channels. Three to four hours were allowed to allow cell attachment onto the walls of the 
channels. To obtain a more homogeneous cell seeding over the channels, a second injection of 
the HUVEC suspension was done after inverting by 180° the chamber. The cells were allowed 
to attach for a time varying between 3-4 h. After this step considered here as time zero, 
microscope images were taken and the cell culture chamber was connected to the bioreactor 
(see supporting information for the detailed sterilization and operation protocol of the 
bioreactor). The pH and DO concentration levels were set to 7.4 and 8.2 mg-L"1, respectively. 
The flow rate of culture medium was adjusted to 2 mL-min"1, corresponding to a shear stress 
of approximately 0.31 Pa. 
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Upon 24h of culture, the chamber was disconnected from the bioreactor (Fig. 3F). To 
fix cells, a paraformaldehyde solution (4% (w/v)) was injected into the channels and the 
samples were incubated at room temperature for overnight. Thereafter, the cell culture 
chamber was disassembled and the gel was carefully removed. Each channel was separated 
and cut into two pieces along its longitudinal axis. Staining for DAPI, actin and vinculin was 
thereafter performed (see cell staining section below). 
Cell Staining 
CFSE Staining 
The 5mM stock solution of 5(6)-carboxyfluorescein diacetate N-succinimidyl ester 
(CFSE) in dimethylsulfoxide (DMSO) was prepared and diluted (1:100) with HBSS. 220nL 
of this solution was added to ImL of cell culture medium and left for 30 min to allow 
sufficient uptake by cells. Thereafter, the cells were washed with HBSS and incubated in pre-
warmed (37°C) Ml99 un-supplemented medium for lh. This staining do not need PFA 
fixation and do not affect cell metabolism. 
Cell Staining for DAPI/Actin/Vinculin 
The cut opened channels with fixed cells were transferred into 24-well plates. Then, 
the samples were washed thrice each 10 min in PBS (37mM NaCl, 2.7mM KC1, 8mM 
Na2HPC>4, 1.46mM KH2PO4) (henceforth IX) under agitation. The cells were permeabilized 
in a saponine solution (0.5% w/v in PBS) for 15 min followed by a washing step in PBS, as 
described above. To block the un-reacted aldehyde groups, the samples were incubated in a 
IX PBS solution containing BSA (1% w/v) and glycine (0.3M) for lh. Primary antibodies 
(vinculin), diluted in IX PBS containing BSA (1% w/v) in a ratio of 1:100 were added to 
some wells and left for at least 2h. The rest of the samples were only incubated in IX PBS 
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solution containing BSA (1% w/v) for further actin staining. This step was followed by 
washing procedure as described above. After that, the secondary antibodies for vinculin, 
diluted in IX PBS (lx) solution containing BSA (1% w/v) in a ratio of 1:500, and phalloidin 
diluted in a ratio of 1:300, were added to some samples and left for lh in the dark. Thereafter, 
all samples were stained using DAPI for 15 min at a final dilution of 1:10000. All secondary 
antibodies were emitting in the red part of the spectrum since the green part was used for 
CFSE. DAPI was checked with UV light. 
3.4 Results and Discussion 
The robust control over important physiological parameters such as pH and DO 
concentration levels is mandatory to obtain a viable cell culture. In the presented bioreactor 
system, changes in pH and DO concentration levels are compensated by PI controlled 
diffusion of CO2 and O2 through gas permeable tubing in the gas exchangers (Fig. 1(2(B-C))). 
The gas exchanger design reported in a previous publication (Chouinard et al. 2009) is not 
compatible with a PI control system. Due to design limitations, the controller responsible for 
the CO2 flow counteracted the controller responsible for O2 flow and vice-versa (Chouinard et 
al. 2009). In addition, the previous gas exchanger made the system too inertial, since there 
was not an efficient way to remove excess of CO2 or O2 gases. To overcome these 
incompatibilities, separate gas exchangers for CO2 and O2 flows with constant flows of air at 
level of 100 mL-min"1 were designed to diminish counteraction of the controllers (Fig. 1(2(B-
C))). The constant flow of air introduced in each gas exchanger plays a dual role. On one 
hand, it helps regulating the partial pressure and thus the solubility of CO2 and O2 and, on the 
other hand, it removes excess of CO2 or O2. This results into a system with less inertia. The 
new design of gas exchangers allows using /7-controlled gas flow meters to modulate transfer 
of CO2 and O2 into the culture medium. 
77 
The PI controllers were set first using MatLab Simulink modelling based on FOPDT 
followed by manual tuning. The open loop dynamic response experiment is a common way to 
determine parameters {TJ, rp, Kp) for first order transfer processes (gas permeation across 
silicone tubing) (DeSutter et al. 2006). The typical CO2 and O2 open-loop dynamic responses 
for our bioreactor at a flow rate of 70 mL-min'1 are shown Figure 4. Even so in the present 
bioreactor design two separate gas exchangers for CO2 and O2 are used, the results from open-
loop experiments indicate an interaction between the gases (O2 and CO2) in the medium. 
Figure 4(A-B) highlights the changes in pH and DO concentration during CO2 open-loop 
experiments. The pH of the circulating medium decreases as expected and stabilizes at a pH 
value of approximately 6.7. At the same time, the DO concentration decreases and stabilizes 
around 6.5 mg-L"1. The trend and shape of the DO concentration curve is similar to the one 
shown in the pH graph, clearly indicating an interaction between the two gases. The changes 
in pH and DO concentration during O2 open-loop experiments are shown in Figure 4(C-D). 
The DO concentration increases as expected and stabilizes at a value of approximately 12 
mg-L'1. It is almost impossible to clearly pinpoint the influence of the added oxygen on pH, 
since the latter constantly increases without constant CO2 supply, as in an incubator. 
The influence of the added CO2 on DO concentration during CO2 open-loop dynamic 
response experiments can be explained as follows. Once the medium reaches the CO2 gas 
exchanger with a CO2 partial pressure of 0.5atm and an O2 partial pressure of 0.1 atm, pH 
decreases owing to CO2 absorption along with a similar trend with DO concentration due to 
O2 desorption. The CO2 absorption can be explained by the increase of CO2 partial pressure 
compared to that in the air at atmospheric pressure (0.039atm), and O2 desorption can be 
explained by the decrease of O2 partial pressure compared to that in the air at atmospheric 
pressure (0.2atm). In the O2 open-loop dynamic response experiments, the increase of DO 
concentration can be explained by the increase of O2 partial pressure from 0.2atm (air at 
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atmospheric pressure) , up to 0.6atm. The increase of the pH during this experiment can be 
explained either by the decrease of CO2 partial pressure from 0.039atm (air at atmospheric 
pressure) to 0.0019atm and/or by the hydrolysis reaction of sodium bicarbonate (buffer agent 
present in the Ml99 medium). 
The open-loop data can be affected by some parameters, such as the presence of the 
second gas exchanger filled only with air, the residence time of the culture medium in this 
unit, and the positions of the pH and O2 sensors. Since the O2 gas exchanger is positioned 
before the second one for CO2, the later is able to remove part of the DO concentration added 
through the first gas exchanger (see Fig. 1). As a result, the DO concentration is at the lowest 
level when the medium reaches the O2 sensor. There is no such pH behavior during CO2 
open-loop experiments, since the pH sensor is positioned directly after the CO2 gas 
exchanger, and as a result, the observed pH of the medium is at the highest level. The 
lowering of the flow in the system (i.e., increase of residence time) results in lower minima 
for DO concentration (O2 open-loop experiments) and lower pH minima (maximum CO2 
absorption). Thus, during open-loop experiments at low flow rates of the culture medium one 
should expect an increased consumption of O2 and a decreased consumption of CO2. For 
schematic explanation, see Figures in Annexes. 
This also explains why at a flow rate of 2 mL-min"1, O2 open-loop experiments cannot 
be carried out with this system even with a fully opened O2 valve (data not shown). The 
residence time of the medium in the second gas exchanger is long enough to counter-balance 
the addition of O2 in the first gas exchanger. 
Based on open-loop experiments, our bioreactor cannot be considered as a single 
input/single output (SISO) system, but rather as a system with multiple inputs. To decrease 
the effect of the interactions between the gases, a decoupler algorithm was implemented into 
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the MatLab Simulink model (Fig. 2A). The decoupler constants (xp) were estimated from 
dynamic open-loop experiments in which both gas valves were fully opened (Fig. 4(E-F)). 
Figure 5 (A-B) shows the performance of the bioreactor at a flow rate of 70mL min*' 
with PI values for the CO2 controller (P: 0.044 and I: 0.055) and O2 controller (P: 0.303 and 
/: 0.05) obtained from the MatLab Simulink model (See supporting info for full table of PI 
values as a function of flow rates). The observed oscillatory behavior of pH and DO 
concentration indicates that PI values estimated by the model are not adequate for our PI 
controllers. Similar oscillatory behavior was observed at 40, 10 and 2 mL-min'1 flow rates 
(data not shown). The most probable reason for such behavior is that the real transfer function 
does not correspond to a perfect first order model. However, this simulation is able to predict 
well P values and to show that D values do not have any impact on the controller behavior. In 
addition, it clearly indicates that I values must be decreased to remove oscillatory behavior. 
Figure 5 (C,D) illustrates the typical response of the bioreactor with PI values of 0.044 
(P) and 0.003 (I) for the CO2 controller and 0.303 (P) and 0.005 (I) values for the O2 
controller at a flow rate of 70 mL-min"1, where the I values for CO2 and O2 controllers were 
decreased 10 and 18 fold, respectively, using a trial-an-error tuning. One can see that the 
system is able to stabilize pH and DO concentration at selected setpoints within 4-5 h and to 
maintain these values for several days. CO2 and O2 controllers operated with the above 
mentioned PI values also show good performance even at flow rates of 40,10 and 2 mL-min'1 
and are able to stabilize pH and DO concentration within a timeframe, which would be 
acceptable for the cells (Fig. 6 (A,C)). At a flow rate of 2 mL-min"1, even so the CO2 
controller is still able to stabilize pH value over a long timeframe the O2 controller is not able 
to reach DO concentration higher than 9 mg-mL'1, even with a fully opened O2 valve. This is 
explained by the effect of the CO2 gas exchanger on DO concentration level with long 
residence time. Overall, the time needed to get to the selected setpoints increases with the 
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decrease of the flow rate within the bioreactor. If the same plots are evaluated on normalized 
scale (reduced time instead of the time scale) to compare the number of cycles needed to 
reach stabilization, the stabilization occurs faster with lower flow rates (Fig. 6(B-D)). The 
most probable explanation for this is that an increase of the residence time of the culture 
medium in the gas exchangers helps saturating the medium with CO2 and O2. 
Overall, the simulation experiments reveal that the transfer function determined using 
an open-loop dynamic response of the bioreactor is unable to perfectly fit the experimental 
data. No further simulation experiments were attempted, since the additional manual tuning 
provided excellent coontro, parameters. 
Figure 7 (B-F) presents the microscopy images of the HUVEC seeded onto the 
channel walls after a 24h culture under bioreactor conditions with circulating medium. The 
pH and DO concentration are controlled by the PI algorithm at a flow rate of 2 mL-min"1. In 
this experiment, only live cells are able to remain attached to the micro-channel walls, since 
dead cells are removed by the shear stress imposed by the flow. To evaluate the influence of 
the bioreactor environment on the cell viability, a few staining techniques including CFSE, 
DAPI, actin, and vinculin are used. CFSE staining allows following live cells during the 
culture and therefore can provide information on cell density by comparing the cultures at 
given time points, without the need to harvest cells (Fig. 7A). After 24h in the bioreactor, 
staining for nuclei (DAPI) confirmed that cell density was similar to the one observed at the 
reference point (Fig. 7B). Cell proliferation was not expected after such short culture time, 
and therefore, no staining to assess proliferation was performed. Interestingly, actin staining 
after 24h of bioreactor experiments showed few elongated cells (Fig. 7C). This may probably 
be a result of the short culture time and/or of an insufficient flow. To the best of our 
knowledge, there are no reports on such bioreactor design, and therefore, the shear stress level 
tolerable by cells still needs to be defined. Vinculin staining showed a few focal adhesion 
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points (Fig. 7D), which is similar to what has been observed under static culture conditions 
(data not shown), where cells were grown in multi-well plates on a gelatin coating. The small 
number of focal contacts could be explained by the softness of the gelatin gel (coating) 
compared to glass or multi-well plates, where focal adhesion points are more apparent. The 
merging picture of actin and DAPI staining is shown in Figure 7E. The findings reported 
above reveal that the bioreactor presented in this study supports cell viability. The 
demonstration of the influence of gravity on cell attachment during cell seeding is illustrated 
in Figure 7F. In fact, it is possible to distinguish two layers of cells, as cells sediment upon 
seeding. This highlights the importance to carry out cell seeding in two different steps by 
flipping the cell culture chamber by 180° to yield more homogeneous cell coverage of channel 
walls. 
3.5 Conclusions 
Important modifications to the bioreactor previously described {Chouinard, 2009 #6} 
have been presented here. The implementation of a second gas exchanger, of a constant 
stream of air to make the system less inert and of the algorithm of the /7-controller represent 
the principal modifications with the aim to control pH and dissolved oxygen (DO) 
concentration. This improved system provides real time control over pH, DO concentration, 
flow rate and temperature. The implementation of a new gas exchanger unit into this 
bioreactor design allows using a PI controller to provide robust control over important 
physiological parameters, such as pH and DO concentration. MatLab Simulink modeling 
. followed by manual tuning have provided acceptable P and / values for the controller. The 
modified system is able to support high cell-density cultures in 3D. 
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3.8 Figure captions 
Figure 1. 1 )  F l o w  c h a r t  o f  t h e  p u l s a t i v e  p e r f u s i o n  b i o r e a c t o r .  2 )  A :  c o m p l i a n c e  c h a m b e r  
serving as heat exchanger and housing for probes; B and C: gas exchanger and drawing 
representing internal part of the gas exchanger; D: Coriolis mass flowmeter, E: pneumatic 
pulsator; F: pressure probe. 
Figure 2. A: Block diagram of the MatLab Simulink model used in our experiments; B and 
C: representative results obtained with the model for CO2 (B) and O2 (C) loops at a flow rate 
of 70 mL-min"1 and PI values (0.044 (P) and 0.055 (I) for CO2 controller and 0.303 (P) and 
0.5 (I) for O2 controller). 
Figure 3. A: drawing of the assembled cell culture chamber; B: picture of the assembled cell 
culture chamber connected to the bioreactor; C: schematic illustration of the gelatin molding 
process. 
Figure 4. A-B: changes of pH and IX) concentration in CO2 open-loop experiments at a flow 
rate of 70 mL-min"1; C-D: changes of pH and DO concentration in O2 open-loop experiments 
at a flow rate of 70 mL-min"1; E-F: changes of pH and DO concentration in CO2 and O2 open-
loop experiments at a flow rate of 70 mL-min"1 performed to determine decoupler constants. 
Figure 5. A-B: changes of pH and DO in bioreactor experiments at a flow rate of 70 mL-min" 
1 with PI values obtained from the MatLab Simulink model (0.044 (P) and 0.055 (I) for CO2 
controller, and 0.303 (P) and 0.5 (/) for O2 controller); C-D: changes of pH and DO in 
bioreactor experiments at a flow rate of 70 mL-min"1 with PI values produced by manual 
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tuning (0.044 (P) and 0.003 (/) for CO2 controller and 0.303 (P) and 0.005 (/) for O2 
controller). 
Figure 6. A-B: changes of pH during bioreactor experiments as function of time (A) and 
number of cycles (B); C-D: changes of DO concentration during bioreactor experiments as 
function of time (C) and number of cycles (D). 
Figure 7. A: CFSE staining of HUVEC at time 0 (before connection to bioreactor), 
magnification 10X. B: DAPI staining of the HUVEC nuclei after 24h under bioreactor 
conditions, magnification 10X. C: Actin staining of HUVEC at 20X magnification. D: 
Vinculin staining, magnification 10X. E: Merge of DAPI and Actin staining, magnification 
10X. F: DAPI staining of 90° rotational view to show cell sedimentation while inoculation. 
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3.9 Annexes 
Sterilization protocol 
1. Wash all tubes, fittings, compliance vessel, caps (remove filter) and bottles with 
Cidezyme enzymatic soap (1.5% (v/v)) (Dismed, Anjou, Qc, Canada). Rinse with 
water and dry with nitrogen gun. 
2. Put the waste bottle with cap, the 250 mL bottle with cap, gas exchangers, Coriolis 
fittings, one filter (cat. # 6713-1650, Whatman) with tube, pressure probe fittings to 
drying cycle in the autoclave (sterilization time: 20 min). The units should be closed, 
when needed, by aluminum foil. 
3. Put the rinse bottle filled with 2L of water with cap but without filter to liquid cycle 
(sterilization time: 30 minutes) and block both extremities with aluminum foil. 
4. Under laminar flow hood, remove aluminum foil protection and connect the filter (cat. 
# 6713-1650, Whatman) to the water-filled rinse bottle. Remove second aluminum foil 
protection and connect sterile 4-way valve (Smith medical). Place the valve to close 
the entrance of the rinse bottle. 
5. Under laminar flow hood, connect a sterile valve to a sterile 0.22jun syringe filter 
(Millex-GP, Millipore, cat. # SLGP033RS). Place the valve to close the entrance of 
the filter. 
6. Under laminar flow hood, remove aluminum foil protection and connect sterile 4-way 
valve (Smith medical). Place the valve to close the entrance of the waste bottle. 
7. On the bioreactor table, assemble as follow: 
The yellow parts are sterile. 
8. Assemble all parts together (gas exchanger, pressure 
probe fitting, Coriolis fittings) except the compliance 
vessel. 
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9. In a clean beaker, prepare a solution of Cidex plus 28 days (Dismed, Anjou, Qc, Can). 
Put both extremities of the tubes of the compliance vessel in the beaker. Start the 
pump to fill all tubes and unit operations with the sterilizing solution. 
10. Under laminar flow hood, remove aluminum protection on the 250mL bottle and 
connect the two tubes to the bottle. Wait 10 hours as recommended by the FDA. 
11. Calibrate the O2 probe with saturated air and pH probe with 3 buffers, disconnect the 
probes and fix the probes to the compliance vessel cap. On the cap of the compliance 
vessel, there should be one tube closed with aluminum foil, one filter (cat. # 6713-
1650, Whatman), one entrance blocked with aluminum foil and the probes. Put the 
compliance vessel with probes in the autoclave to drying cycle (sterilization time: 20 
min). 
12. Change valve orientation to introduce sterilizing solution into the waste bottle. Let 
enter sterile water to remove any residual sterilizing solution. Put water in waste bottle 
and re-do the step at least four times. Put all solutions in waste bottle and stop the 
peristaltic pump. 
13. Under the laminar flow hood, remove aluminum foil protection on compliance vessel 
tube and connect sterile filter (Millipore, cat. # SLGP05010). On that filter, connect 
another tube to place in the supplemented cell culture medium. On the other filter (cat. 
# 6713-1650, Whatman) of the compliance vessel, connect one tube connected to a 
vacuum pump. Start the vacuum pump. The medium will pass through the filter 
(Millipore, cat. # SLGP05010) and enter into compliance vessel. At the end, stop the 
vacuum pump; remove all the tube linked to Millipore, cat. # SLGP05010. 
14. Under laminar flow hood, remove the last aluminum foil protection on the compliance 
vessel cap. Take the 250mL bottle under the hood and connect the tube of the 250mL 
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bottle to the cap of the compliance vessel. Connect the cell culture chamber right after 
the exit of the compliance vessel. 
15. Reconnect the probe to the transmitters and connect the jacket to the heat bath to 
adjust temperature to 37°C. 
16. Start the Labview routine to control parameters. 
Partial pressure diagram inside gas exchangers 
A) Gas mixture Gas mixture 
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Figure 5 
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Figure 7 
APPENDICE AU CHAPITRE 3 : 
AMELIORATION DU DESIGN POUR REDUIRE 
LES RISQUES DE CONTAMINATION ET POUR 
AUGMENTER LA CROISSANCE CELLULAIRE 
A.1 Introduction 
Ce qui a £te pr£sent£ jusqu'& maintenant aux Chapitres 2 et 3 sont les r^sultats de 
l'application du syst&me. Cependant, depuis les deux derni&res annees et demi, le proc6de n'a 
jamais cesse d'evoluer. Plusieurs essais et erreurs ont mene au design final et au protocole 
op&ationnel final (SOP). Ce qui sera pr^sente dans cette section est le rationnel derri&re tous 
les probtemes rencontres et qui justifient les modifications du design. Ainsi, les modifications 
du precede, de la chambre de culture cellulaire et les moyens pour r&iuire les risques de 
contamination seront exposes. 
A.2 Modifications du bior£acteur 
La Figure 1A montre la photographie et le diagramme blocs du r£acteur au 
commencement de ce projet de recherche. Chaque operation unitaire £tait continue dans un 
abri ferm£ pour r6duire le bruit et pour prot£ger les instruments. L'abri ferm6 a et6 enlev6 
puisqu'il Itait impossible d'avoir un acc&s ad£quat et le manque d'espace constituait un r6el 
probteme. figalement, la sonde b temperature a 6t€ enlev£(e) puisque la sonde k oxyg&ne 
dissout mesure 6galement la temperature et il 6tait possible de faire l'acquisition de ces 
donn£es. La chambre de compliance ou pi&ge k bulles a 6t6 enlevde puisque la bouteille de 
2S0mL avait le meme role et que le syst£me agissait en circuit fermd. Les bouchons des 
bouteilles ont 6t6 remplacls par un autre syst&me puisque les bouchons de caoutchouc avaient 
tendance & craquer autour des tiges de m£tal qui siphonnaient les liquides. Toutes les tubes 
ont 6t6 changes pour utiliser un matdriau avec une meilleure biocompatibilitl, anti adh£sivit£ 
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aux prolines et reconnu pour ses applications en biotechnologie/industrie pharmaceutique. 
La taille de la majority des tubes a ete chang^e de 3/8" k 1/8" ID. Cette modification a permis 
de r&iuire, pour une meme longueur, le volume d'un facteur 9, rgduisant les coQts relics k 
chaque experience par 1'utilisation de milieu supplement^. La tete de pompe a ete changee 
pour diminuer le debit volumetrique minimal. En changeant la taille des tubes et la tete de 
pompe, le debit volumetrique minimal est passe de 20mL/min & 2mL/min. Cette modification 
etait essentielle k ce projet puisque les cellules sont exposees directement k recoupment et la 
possibilite de "wash out" etait preoccupante. 
Ceci a mene £ la seconde version du bioreacteur. De cet ancien design, le contrdle du 
pH et de la concentration en 02 n'etait pas possible. Les debitmfetres gazeux utilises etaient 
pour des applications industrielles tandis que le volume du reacteur est beaucoup trop petit 
pour permettre une injection adaptee. Les probtemes relies k l'ancien design ont ete reportes 
au Chapitre 3. Brifcvement, il y avait une seule entree pour les gaz, le systfcme etait inerte 
(aucune fafon d'enlever le surplus) et les deux gaz etaient en competition pour le meme 
echangeur de gaz. Ainsi, de nouveaux debitmfetres massiques ont ete introduits, un debit d'air 
constant a permis au systfcme d'etre moins inerte (et enlever les surplus) et un deuxi&me 
echangeur de gaz a ete place en serie avec le precedent. 
figalement, une complication rencontr6e etait le contrdle de la temperature. Avec la 
longueur de tubes necessaire pour connecter la chambre de culture cellulaire sous la hotte & 
flux laminaire, il etait impossible d'atteindre la valeur cible. II etait egalement impossible 
d'augmenter la temperature du bain-marie puisqu'il aurait fallu augmenter la temperature k un 
point tel que les proteines du milieu de culture auraient pu se denaturer. Simplement entre 
rechangeur de temperature et la sonde a oxygfcne, plusieurs degres Celsius etaient perdus & un 
debit volumetrique de 2mL/min et la chambre de culture cellulaire etait assez loin de la sonde 
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k oxygfcne. L'isolation des tubes n'a pas permis de r€gler le probl&me. Le probl&me etait 
present uniquement aux plus faibles dibits. 
Une autre version a permis d'amllioier le procede (Figure IB). Les supports & sondes 
n'6taient pas capables de maintenir la st£rilit£ (voir Section A.4) malgre un rt-usinage 
complet des pieces. Ce problfcme, combing au probl&me de perte de temperature, a men£ & au 
compartiment de compliance. Cette nouvelle operation unitaire a permis d'eiiminer la 
contamination qui venait des supports & sondes. Les sondes sont directement vissees dans le 
couvercle et des joints toriques assurent 1'etancheite. Puisque le compartiment de compliance 
poss&de une double-paroi, l'echangeur de temperature a ete enleve et le milieu chauffant est 
passe directement k travers la double-paroi. La bouteille de 250mL n'etait egalement plus 
necessaire puisque le compartiment de compliance agit egalement de la meme fa9on. Le 
contrdle de la temperature est direct (sans deiai) puisque la sonde & oxyg&ne est connectee & la 
meme unite qui chauffe et lit les mesures. Finalement, toute cette unite est transportee sous la 
hotte lorsque la chambre de culture cellulaire est connectee. Ainsi, la chambre de culture est 
directement positionnee aprfes les sondes pour assurer une precision accrue. Le milieu de 
culture est introduit dans le compartiment de compliance sous la hotte & flux laminaire et cela 
permet de faire des changements de milieu pour faire des experiences k long terme. 
A.3 Designs des chambres de culture cellulaire 
Une des premieres etapes dans ce projet a ete de bien designer une chambre de culture 
cellulaire. Le design initial est pr^sente k la Figure 2A. Cela consiste en une chambre 
cylindrique de polycarbonate avec douze canaux. Malheureusement, il etait difficile de 
prendre des images satisfaisantes k cause des aberrations spheriques dues k la geometrie de la 
chambre. Ainsi, le gel devait etre enleve pour avoir une bonne resolution des images (Figure 
2B). Ainsi, un autre design similaire, avec la partie centrale en verre, a ete construit par le 
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souffleur de verre. Pour eviter les aberrations sphlriques, deux fenetres planes etaient 
fusionnees k la partie centrale. Cependant, ces fenetres cr£aient un volume supplementaire de 
gel et l'epaisseur de ce gel supplementaire faisait en sorte qu'aucunes cellules n'etaient visibles 
par les fenetres. Les seules cellules visibles etaient directement k travers la paroi (avec des 
aberrations spheriques) avec une magnification basse (ster6o-microscopie) (Figure 2D). La 
presence de douze canaux donnait lieu k plusieurs canaux bloques et le temps de construction 
etait assez long. 
Le deuxi&me design de chambre de culture cellulaire est celui utilise dans les 
Chapitres 2 et 3. Pour cette raison, aucun detail supplementaire ne sera donne. La Figure 3 
(A-B) montre la plus forte densite cellulaire obtenue avant branchement au bioreacteur tandis 
que la Figure 3 (C-D) montre les deux principales sources de "troubleshooting", c'est-^-dire 
l'entree de bulles et l'encombrement des canaux par de petits morceaux de gelatine. 
Le troisi&me design de chambre de culture cellulaire est un prototype pour proteger les 
cellules du "wash out" cause par l'ecoulement (Figure 4A). Puisque le but de ce projet de 
recherche etait de diriger l'adhesion cellulaire vers la geometrie d'un micro-vaisseau, ce 
nouveau design a ete congu en gardant le plus possible la forme cylindrique. Au lieu de quatre 
canaux, il y avait uniquement deux canaux. Les composantes sont assez similaires. La 
chambre de culture cellulaire avec aiguilles est remplie d'une solution de gelatine et 
d'enzymes pour l'enchevetrement des proteines jusqu'i la geiification. Ensuite, les aiguilles 
sont enlevees pour creer 2 canaux. Deux nouvelles pieces (un cote ferme et un cote ouvert) 
sont vissees sur les cotes de la chambre pour parfaitement aligner le centre du canal et 
permettre {'introduction d'une deuxi£me aiguille plus petite que la premiere. Une seringue 
remplie d'un mixte de gelatine, d'enzymes, de cellules et de milieu de culture suppiemente est 
attachee a l'aiguille et la solution est injectee pour remplir l'interstice entre l'aiguille et le 
premier canal. Aprds six heures de geiification, l'aiguille est enlevee pour creer une lumi£re. 
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Le milieu de culture peut circuler dans la lumi£re tandis que les cellules sont emprisonn£es 
dans le gel dans une forme cylindrique (Figure 4B). Les experiences en statique demontrent 
des resultats prometteurs. Toutefois, malgre un bon nombre de cellules vivantes, un nombre 
sup&ieur de cellules mortes a ete observe par coloration live/dead (Figure 4C). Ainsi, les 
conditions optimales de milieu, gel, enzymes et cellules restent k determiner. 
A.4 Contamination 
La presence de contaminations a ete probablement le plus gros defi de ce projet de 
recherche. Le procede ne peut etre enticement autoclave et plusieurs techniques (filtration, 
sterilisation chimique) doivent etre tentees pour empecher la croissance de microorganismes 
non desires. II n'y a aucune place k 1'erreur puisque le milieu de culture utilise permet une 
proliferation rapide avec des concentrations optimales en sucres, vitamines, etc.. II existe trois 
options pour expliquer une contamination : un mauvais protocole, un mauvais utilisateur ou 
un mauvais design/procede. 
Initialement, la procedure de sterilisation utilisait du javellisant (ingredient actif : 
sodium hypochlorite). Malheureusement, cela entrainait une severe deterioration (rouille, 
pitting) k certaines parties en acier inoxydable. A cause de la severite des dommages, un agent 
sterilisant plus doux a ete utilise. 
Dans les experiences, trois observations pouvaient permettre la conclusion d'un milieu 
contamine : la turbidite du milieu de culture (perte de la transparence), le test GRAM et une 
chute prononcee de la concentration en oxyg&ne dissout. Parmi les tests de contamination, le 
type etait toujours bacterien. Pour permettre de cibler la source de contamination, le protocole 
complet de sterilisation a ete suivi avec une la connexion en serie d'une seule operation 
unitaire (ex.: tubes, Coriolis, echangeur de chaleur, supports k sonde, echangeurs de gaz). Du 
milieu de culture circulait pendant environ 12h et par la suite, un certain volume etait preieve 
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sous la hotte et place dans un contenant T-flasque pour evaluer la contamination. 
Normalement, la contamination est visible apr£s 36h. Cette serie d'experiences a demontre 
que le protocole n'etait pas responsable de la contamination puisque les tubes, le Coriolis et 
l'&hangeur de temperature n'ont montre aucun signe de contamination. L'option du mauvais 
utilisateur a egalement ete ecartee puisque les experiences ont ete reproduites avec les memes 
resultats. Ainsi, le design de nouveaux supports k sonde k pression et de nouveaux echangeurs 
de gaz ont ete fabriques (voir Chapitre 3). Le support k sonde k pH et O2 est remplace par le 
compartiment de compliance. 
Une fois les nouveaux designs fabriques, un protocole adapte aux nouvelles operations 
unitaires a ete introduit. Finalement, les experiences ont demontre une sterilite pendant trois 
semaines (trois fois consecutives). 
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A.5 L6gende des figures 
Figure 1: A: Image du bior&cteur avant optimisation et validation. Le diagramme bloc 
montre rarrangement des operations unitaires. B: Image du bioreacteur aprds optimisation et 
validation. 
Figure 2: Chambre de culture cellulaire et r&ultats. A: Image de la chambre de culture en 
polycarbonate. B: Adhesion cellulaire en statique avec le design en A (culture de HUVEC). 
Images prises par Fabienne Glacial. C: Vue enti&re de la chambre de culture cellulaire en 
verre creee par SOLID WORK. D: Adhesion cellulaire en statique avec la chambre de culture 
cellulaire en verre (culture de HUVEC). 
Figure 3: Images avec l'actuelle chambre de culture cellulaire en statique (cellules attachees 
sur les parois). A: Microscopie confocale de HUVEC avec coloration au CFSE, h 
magnification 10X. B: Microscopie interferentielle en lumi6re visible de HUVEC. C: 
Morceaux de gelatine qui bloquent un canal D: Bulles prises dans un canal. 
Figure 4: Chambre de culture cellulaire prototype en geometrie annulaire (cellules dans le 
gel). A: Vue SOLID WORK avec les deux nouvelles pieces de chaque cote pour aligner les 
aiguilles au centre du canal precedemment cree. B: Experience en statique en lumi£re visible 
ou on peut voir facilement les trois parties, c'est-&-dire la lumi£re, les cellules dans le gel et le 
gel (magnification 4X). C: Coloration live-dead. Rouge-dead et Vert-live (HUVEC, 
magnification 4X). 
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CONCLUSIONS 
Ce m&noire porte sur la caracterisation, l'optimisation et la validation d'un rlacteur 
pour des applications en genie tissulaire pour la culture de substituts tissulaires 
tridimensionnels. La caracterisation de ce reacteur repose sur une etude de la distribution des 
temps de residence dans le proc&ie et des experiences de permeabilite k l'interieur de la 
chambre de culture cellulaire par une sonde fluorescente ou par MRI. L'etude RTD a 
demontre un nombre de Peclet (reacteur) variant de 50 k 70, ce qui correspond k un degre 
modere k eieve de dispersion. A partir de l'analyse d'un cycle simple, il a ete possible de 
distinguer la presence de zones mortes et de melange contre-courant. A partir des resultats de 
l'analyse de cycles multiples (en boucle fermee), il apparait que le volume de la chambre de 
compliance affecte davantage la dynamique d'ecoulement comparativement k d'autres facteurs 
tels le debit et l'agitation (dans cette chambre). L'introduction d'une nouvelle equation 
empirique a permis de bien predire les minima de la fonction \|/(6) des RTD. Les experiences 
de permeabilite de la rhodamine B k l'interieur d'une region d'interet (ROI) predetermine 
n'ont demontre aucune difference statistique entre un hydrogel de gelatine avec cellules 
(8xl05c/mL) et un hydrogel de gelatine sans cellules. Ce resultat est probablement explicable 
par le choix de la concentration cellulaire dans l'hydrogel qui n'est pas du meme ordre de 
grandeur qu'une densite in vivo. Ainsi, la densite cellulaire utilisee dans cette experience 
represente environ 0.16% la densite cellulaire de certains tissus. Par consequent, le volume 
occupe par les cellules etait negligeable comparativement au gel et aucune difference dans la 
permeabilite du gel k la rhodamine B dans le ROI ne fQt visible entre les echantillons avec et 
sans cellules. Les experiences statiques en MRI ont permis de calculer le coefficient de 
diffusion apparent de l'eau, eliminant la contrainte convective. Les resultats MRI concordent 
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avec les resultats de la permeabilite et aucune difference entre les echantillons n'a ete 
observee. 
Le processus d'optimisation a repose sur plusieurs aspects differents. L'introduction de 
deux algorithmes proportionnel-integral pour contrdler le pH et l'oxyg&ne est la contribution 
la plus importante au reacteur. Apr£s les experiences en boucle ouverte, une simulation 
SIMULINK avec un modele du premier ordre comportant un deiai (FOPDT) a permis de 
trouver les valeurs d'essais initiaux des param&tres P et /. Puisque le syst£me ne repond pas 
parfaitement k rhypothdse avancee d'une fonction de premier ordre, le param&tre integral (/) a 
ete par la suite modifie manuellement pour eiiminer les oscillations. L'optimisation repose 
egalement sur le bon design des operations unitaires. Ainsi, k travers les nouveaux designs des 
echangeurs de gaz, du support de la sonde a pression, du couvercle de la chambre de 
compliance et des chambres de culture cellulaire, il a ete possible de diminuer au maximum 
les risques de contamination en enlevant des connections, des zones mortes et en choisissant 
des materiaux sterilisables par autoclave. Le protocole de sterilisation, lequel contient des 
etapes d'autoclave, de filtration et de sterilisation chimique, a conserve une sterilite pendant 
plus de trois semaines, laissant presager la possibilite de faire des cultures k tr£s long terme. 
L'optimisation des chambres de culture cellulaire a permis de creer deux differents designs ou 
les cellules peuvent etre attachees aux parois de l'echafaudage ou emprisonnees dans le gel en 
geometrie annulaire. Toutefois, seulement le premier design a ete valide en conditions 
dynamiques. 
La validation du reacteur a ete realisee grace & l'utilisation de la chambre de culture 
cellulaire pour cultiver des cellules endothelials (HUVEC) pendant 24 heures. Apr£s 24 
heures, la densite cellulaire etait similaire a celle au temps initial. Les cellules sont done 
restees attachees 4 la surface aprds une exposition k un ecoulement creant une contrainte de 
cisaillement d'environ 0.31 Pa. Apr&s l'experience, la fixation au PFA a egalement permis une 
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deuxidme etape de solidification de l'hydrogel en plus de fixer les cellules. Ainsi, le gel a pu 
etre retire aisement du la chambre de culture cellulaire pour ensuite etre decoupe en tranches 
pour permettre la coloration a differents marqueurs. Les marqueurs utilises (actin, DAPI) 
laissent presager d'autres applications pour des marqueurs de la fonctionnalite vasculaire 
(eNOS) ou pour la proliferation (Ki67). 
Ce reacteur est enti&rement operationnel pour etudier plusieurs pararnetres 
physiologiques tels le pH, la concentration en oxyg&ne, le debit et la pulsation. Le reacteur est 
extremement polyvalent puisque plusieurs chambres de culture cellulaire peuvent y etre 
attachees. Dans ce memoire, une chambre de culture cellulaire a ete validee et une seconde est 
au stade du developpement. Le protocole pour permettre l'utilisation des marqueurs 
d'angiogen£se est egalement complete. 
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